GI-bleeding

K11_GIBLEEDING

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — K92.0, K92.1, K92.2 Hospital discharge: ICD-9 — 578 Cause of death: ICD-10 — K92.0, K92.1, K92.2 Cause of death: ICD-9 — 578 2 out of 7 registries used, show all original rules.	16237
4. Check minimum number of events None	16237
5. Include endpoints None	16237
6. Filter based on genotype QC (FinnGen only)	15693

Control definitions (FinnGen only)

Control exclude: K11_OTHDIG

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2

NAME	K11_GIBLEEDING
CONTROL_EXCLUDE	K11_OTHDIG
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	K92[0-2]
HD_ICD_9	578
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	K92[0-2]
COD_ICD_9	578
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to GI-bleeding based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	15693	6246	9447
Unadjusted period prevalence (%)	3.49	2.22	4.33
Median age at first event (years)	67.01	65.69	67.88

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
16235: Matched controls
162309

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.9

323.0

1711

6399

WX892

NOMESCO Finland

Monitored bed care

2.8

316.8

1779

6859

F10.25

ICD-10 Finland

Alcohol dependence continuous use

6.5

309.6

516

819

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

5.1

307.8

666

1351

K26.0

ICD-10 Finland

Duodenal ulcer, acute with haemorrhage

22.4

307.7

610

282

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.3

307.7

3278

16337

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.1

307.7

4009

21875

UJF32

NOMESCO Finland

Coloscopy

3.8

307.7

7076

27304

K26.4

ICD-10 Finland

Duodenal ulcer, chronic or unspecified with haemorrhage

18.5

307.7

284

156

TPH04

NOMESCO Finland

Cathetrisation of vein

2.2

307.7

4340

23058

K25.0

ICD-10 Finland

Gastric ulcer, Acute with haemorrhage

22.7

307.7

953

445

WW500

NOMESCO Finland

Blood transfusion

4.6

307.7

1206

2802

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

8.0

307.7

10334

29272

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

126.5

307.7

4409

477

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.6

307.7

2098

8611

K92.1

ICD-10 Finland

Melaena

222.8

307.7

9360

986

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

2.5

307.7

4072

19161

JDA42

NOMESCO Finland

Other endoscopic haemostatic procedure in stomach or pylorus

30.2

307.7

308

104

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

9.8

307.7

682

726

JDA32

NOMESCO Finland

Endoscopic injection in stomach or pylorus

33.4

307.7

279

JCA22

NOMESCO Finland

Endoscopic ligature of oesophageal varices

41.3

307.7

308

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.9

307.7

8261

57529

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

3.7

307.7

2235

6720

C03CA01

ATC

furosemide; systemic

2.1

307.7

7179

43999

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

5.7

307.7

2057

4059

K25.9

ICD-10 Finland

Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation

7.1

307.7

728

1065

K25.4

ICD-10 Finland

Gastric ulcer, Chronic or unspecified with haemorrhage

14.7

307.7

497

347

I85.0

ICD-10 Finland

Oesophageal varices with bleeding

45.1

307.7

336

K22.6

ICD-10 Finland

Gastro-oesophageal laceration-haemorrhage syndrome

32.6

307.7

497

157

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.2

307.7

3652

18733

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

7.7

307.7

595

794

UJD02

NOMESCO Finland

Gastroscopy

4.3

307.7

1393

3493

JN3AD

NOMESCO Finland

Abdominal CT examination

2.9

307.7

2599

9937

I85.9

ICD-10 Finland

Oesophageal varices without bleeding

17.4

307.7

542

321

ZXD05

NOMESCO Finland

Urgent procedure

2.0

307.7

5523

33699

5781A

ICD-9 Finland

Gastro-intestinal haemorrhage, Melaena[MELAENA]

+∞

307.7

426

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

8.2

307.7

1736

2334

A02BC02

ATC

pantoprazole; systemic

3.1

307.7

12498

84837

K25.3

ICD-10 Finland

Gastric ulcer, Acute without haemorrhage or perforation

9.4

307.7

393

427

UJF92

NOMESCO Finland

Capsular endoscopy

9.9

307.7

846

893

D62

ICD-10 Finland

Acute posthaemorrhagic anaemia

10.2

307.7

501

503

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

4.1

307.7

1830

4849

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.7

307.7

2966

12517

UJF30

NOMESCO Finland

Ileoscopy through colon

2.9

307.7

2116

7994

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.2

307.7

6295

36685

K92.0

ICD-10 Finland

Haematemesis

705.5

307.7

4419

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

3.2

307.7

2063

7045

D64.9

ICD-10 Finland

Anaemia, unspecified

3.4

307.7

3361

11431

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.6

306.5

2038

8547

F10.24

ICD-10 Finland

Alcohol depence active use

7.3

302.4

451

636

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

6.7

301.3

482

733

N02AX02

ATC

tramadol; systemic, rectal

1.8

290.7

7388

50989

P15

ICPC

Chronic alcohol abuse

4.6

277.3

680

1530

K26.3

ICD-10 Finland

Duodenal ulcer, acute without haemorrhage or perforation

12.9

276.6

267

210

F10.20

ICD-10 Finland

Alcohol dependence currently independent

5.6

275.8

530

966

TPH07

NOMESCO Finland

Cathetrisation of artery

2.3

275.8

2351

11009

R11

ICD-10 Finland

Nausea and vomiting

2.6

275.4

1749

7155

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.6

273.3

1754

7211

5780A

ICD-9 Finland

Gastro-intestinal haemorrhage, Haematemesis

+∞

268.4

257

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.2

265.2

2479

12052

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.9

259.2

1360

5038

K22.1

ICD-10 Finland

Ulcer of oesophagus

5.1

258.5

552

1106

C03DA01

ATC

spironolactone; oral

2.2

256.7

2628

13238

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.3

252.0

2228

10567

A06AD11

ATC

lactulose; oral

2.0

251.3

3267

17985

A02BC01

ATC

omeprazole; systemic

1.8

247.5

4874

30755

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.8

243.1

5196

33572

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

5.8

241.5

449

793

K92.9

ICD-10 Finland

Disease of digestive system, unspecified

23.6

241.4

173

I50.9

ICD-10 Finland

Heart failure, unspecified

2.0

240.6

3460

19696

R53

ICD-10 Finland

Malaise and fatigue

1.9

239.2

4217

25657

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.2

237.1

2194

10586

N07BB01

ATC

disulfiram; oral

3.5

235.5

841

2479

5781B

ICD-9 Finland

Gastro-intestinal haemorrhage, Melaena[HAEMORRHAGIA EX ANO]

+∞

233.9

224

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

3.1

233.7

1065

3643

ZX120

NOMESCO Finland

Intravenous

2.4

233.3

1819

8157

AA1AD

NOMESCO Finland

CT of head and brain

1.8

233.2

5048

32653

N02AA05

ATC

oxycodone; systemic

1.9

231.4

3501

20240

A02BC05

ATC

esomeprazole; systemic

1.7

228.8

6355

44072

A02BC03

ATC

lansoprazole; oral

1.8

221.3

4820

31140

T36

ICD-10 Finland

Poisoning by systemic antibiotics

3.6

220.3

770

2237

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

6.6

218.2

355

549

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

5.1

216.0

463

930

F10.09

ICD-10 Finland

Alcohol intoxication UNS

4.8

213.0

488

1037

J01MA02

ATC

ciprofloxacin; systemic

1.7

212.4

6713

47925

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.0

210.7

2748

15048

B01AB05

ATC

enoxaparin; parenteral

1.7

209.3

5250

35185

XF400

NOMESCO Finland

ECG with 12 standard connections

1.9

206.8

3110

17863

K70.1

ICD-10 Finland

Alcoholic hepatitis

10.3

205.8

230

226

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

3.9

203.6

628

1675

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.7

200.5

5508

37736

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

6.8

199.9

317

477

K70.4

ICD-10 Finland

Alcoholic hepatic failure

13.5

199.4

187

140

N05CF01

ATC

zopiclone; oral

1.7

196.5

5541

38176

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.2

196.5

1826

8786

C07AB07

ATC

bisoprolol; oral

1.6

194.0

8549

65857

N05AH04

ATC

quetiapine; oral

1.9

193.9

2707

15133

A07EC02

ATC

mesalazine; oral, rectal

2.9

192.8

972

3510

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

3.2

192.6

808

2628

D15

ICPC

Melaena

12.3

192.4

191

157

N06AX11

ATC

mirtazapine; oral

1.7

191.7

5192

35339

P01AB01

ATC

metronidazole; oral, rectal

1.7

189.2

5647

39395

K55.8

ICD-10 Finland

Other vascular disorders of intestine

10.0

186.9

213

215

R18

ICD-10 Finland

Ascites

4.3

185.7

494

1182

WX408

NOMESCO Finland

General anesthesy, balanced

1.7

183.8

4115

26537

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

6.1

182.4

317

524

R06.0

ICD-10 Finland

Dyspnoea

1.7

180.2

4523

30069

K26.9

ICD-10 Finland

Duodenal ulcer, unspecified as acute or chronic, without haemorrhage or perforation

6.2

180.0

311

511

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

3.2

178.8

760

2490

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.9

177.5

2711

15569

K90.0

ICD-10 Finland

Coeliac disease

8.4

176.7

231

279

R50.9

ICD-10 Finland

Fever, unspecified

1.9

176.5

2603

14777

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

3.1

176.4

769

2557

B01AA03

ATC

warfarin; systemic

1.7

174.6

4140

27060

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.7

174.5

983

3759

J01MA12

ATC

levofloxacin; systemic

1.8

173.9

3323

20431

TK800

NOMESCO Finland

Hemodialysis

3.9

173.2

517

1346

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.7

170.3

4653

31541

N02BE01

ATC

paracetamol; systemic, rectal

1.9

169.7

13775

121816

Z3231

NOMESCO Finland

Registered nurse

1.7

168.9

4535

30587

WX002

NOMESCO Finland

Sedation and analgesia

1.8

168.9

3231

19851

A07AA11

ATC

rifaximin; oral

18.1

168.3

135

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

3.7

166.5

550

1536

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

3.6

166.0

557

1572

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.8

165.6

2808

16628

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

2.5

161.9

1115

4698

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

5.2

160.1

330

640

H02AB06

ATC

prednisolone; systemic

1.6

159.9

7455

57184

UJF02

NOMESCO Finland

Peroral enteroscopy

8.9

159.9

199

226

JCA32

NOMESCO Finland

Endoscopic injection in oesophagus

30.2

159.7

105

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

2.4

159.6

1176

5108

JN4AD

NOMESCO Finland

Body CT examination

2.0

159.1

1833

9533

K55.2

ICD-10 Finland

Angiodysplasia of colon

7.0

157.9

240

345

J01DB01

ATC

cefalexin; oral

1.7

157.7

12512

108328

N05BA04

ATC

oxazepam; oral

1.7

156.6

4036

26840

TKC20

NOMESCO Finland

Catheterisation of bladder

2.2

156.4

1465

7040

B82

ICPC

Anaemia other/unspecified

3.2

156.2

628

1988

P16

ICPC

Acute alcohol abuse

4.8

155.7

354

747

K20

ICD-10 Finland

Oesophagitis

4.4

154.9

401

939

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

4.3

154.9

412

985

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.6

154.2

942

3747

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.2

154.1

1447

6959

Z2446

NOMESCO Finland

Social worker

2.4

153.1

1129

4904

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

6.8

150.8

236

350

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

2.3

150.6

1295

6008

JAH00

NOMESCO Finland

Laparotomy

3.2

147.6

600

1912

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.9

146.9

702

2456

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

2.4

146.8

1033

4391

K29.0

ICD-10 Finland

Acute haemorrhagic gastritis

6.6

146.6

238

367

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.0

145.1

1739

9156

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

6.6

144.8

234

359

K29.2

ICD-10 Finland

Alcoholic gastritis

13.1

144.0

137

105

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

5.7

143.4

268

475

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.3

143.4

1123

5004

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.8

142.6

2467

14636

K86.08

ICD-10 Finland

Alcohol-induced chronic pancreatitis

9.3

140.2

169

184

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.7

139.1

772

2924

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.5

138.1

915

3780

N06AB04

ATC

citalopram; systemic

1.7

137.3

3122

19991

K25.7

ICD-10 Finland

Gastric ulcer, Chronic without haemorrhage or perforation

5.1

136.9

290

576

ZXE00

NOMESCO Finland

One hour or less

1.5

136.7

5821

43304

C07AA05

ATC

propranolol; systemic

1.7

135.2

2679

16509

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.6

134.1

5131

37245

L04AX01

ATC

azathioprine; systemic

2.8

133.7

714

2650

A03FA01

ATC

metoclopramide; systemic, rectal

1.7

133.3

3230

21012

JCA42

NOMESCO Finland

Other endoscopic procedure for hemostasis

27.4

132.6

SPAT1263

SPAT

Sampling

1.5

132.5

6277

47678

M04AA01

ATC

allopurinol; systemic

1.7

132.1

2632

16235

D16

ICPC

Rectal bleeding

3.5

131.7

472

1390

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.7

131.6

2576

15808

Z2221

NOMESCO Finland

Medical doctor

1.6

131.4

4080

28205

R07.4

ICD-10 Finland

Chest pain, unspecified

1.6

131.2

4453

31429

B80

ICPC

Iron deficiency anaemia

3.4

128.6

470

1401

N05BA01

ATC

diazepam; systemic, rectal

1.8

128.3

2102

12236

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

4.5

128.2

316

712

N03AX16

ATC

[U] pregabalin

1.6

128.1

3484

23303

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.9

127.5

1946

11079

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

5.7

127.3

240

429

A09AA02

ATC

multienzymes (lipase, protease etc.); oral

3.5

127.1

442

1276

A02BA02

ATC

ranitidine; systemic

1.6

126.7

3217

21144

I50.0

ICD-10 Finland

Congestive heart failure

1.9

126.4

1751

9662

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.9

126.2

1892

10709

J01FF01

ATC

clindamycin; systemic

1.6

125.2

3983

27640

JN4BD

NOMESCO Finland

Extensive body CT

1.9

125.0

1804

10086

A46

ICD-10 Finland

Erysipelas

1.7

123.7

2579

16081

K29.7

ICD-10 Finland

Gastritis, unspecified

2.7

122.5

674

2540

D64.8

ICD-10 Finland

Other specified anaemias

3.5

122.4

429

1245

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.7

122.1

2400

14716

SPAT1254

SPAT

Administration of medicine

1.7

122.1

2630

16538

ZXE10

NOMESCO Finland

More than one and less than three hours

1.5

121.8

5429

40522

K51.5

ICD-10 Finland

Left sided colitis

3.3

121.2

461

1409

X59

ICD-10 Finland

Exposure to unspecified factor

1.7

121.2

2833

18203

3AC01, ,

NOMESCO Finland

5.2

120.9

250

486

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

3.1

120.7

507

1646

D50.8

ICD-10 Finland

Other iron deficiency anaemias

4.1

120.5

333

819

JFB00

NOMESCO Finland

Partial resection of small intestine

3.9

120.2

365

961

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.6

119.4

3186

21160

WX302

NOMESCO Finland

Thoracal epidural anesthesy

2.4

119.4

907

3981

A28

ICPC

Limited function/disability NOS

1.6

118.9

3189

21204

A11CC03

ATC

alfacalcidol; systemic

3.1

118.8

503

1641

R4110

NOMESCO Finland

Physiotherapy

1.6

118.8

4149

29351

K50.9

ICD-10 Finland

Crohn disease, unspecified

4.5

117.7

288

645

K70.9

ICD-10 Finland

Alcoholic liver disease, unspecified

9.9

116.2

133

135

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.5

116.1

4178

29723

A04

ICPC

Weakness/tiredness general

1.7

116.1

2375

14709

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.1

115.4

1229

6178

JDH25

NOMESCO Finland

Other endoscopic haemostatic procedure in duodenum

26.5

114.9

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

3.4

113.3

411

1219

SPAT1301

SPAT

No procedures

1.5

111.9

4876

36072

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.8

111.9

563

2023

Z3226

NOMESCO Finland

Physiotherapist

1.6

111.7

2773

18053

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

111.4

6313

49196

B01AB10

ATC

tinzaparin; parenteral

1.9

110.8

1496

8167

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.6

109.9

2712

17623

N06AX16

ATC

venlafaxine; oral

1.8

109.0

1704

9745

ZXE20

NOMESCO Finland

More than three and less than five hours

1.7

108.9

2196

13527

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.8

108.1

1920

11407

R51.80

ICD-10 Finland

Headache

1.8

108.1

1972

11809

Z49.1

ICD-10 Finland

Extracorporeal dialysis

4.0

108.0

307

771

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.5

107.1

4409

32179

N05AA02

ATC

levomepromazine; systemic

2.5

107.0

681

2755

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.5

107.0

4589

33772

E87.6

ICD-10 Finland

Hypokalaemia

2.7

107.0

619

2391

TPX10

NOMESCO Finland

Implantation of vascular injection port

2.8

106.6

537

1931

A06AC01

ATC

ispaghula (psylla seeds); oral

1.5

106.3

3872

27526

WX402

NOMESCO Finland

General anaesthesia

1.6

106.2

2797

18454

WZC00

NOMESCO Finland

Treatment plan or consultation

1.5

106.1

5008

37565

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.1

105.5

1106

5523

SPAT1255

SPAT

Intravenous administration of medicine

2.0

104.1

1166

5964

A10AB05

ATC

insulin aspart; parenteral

2.0

104.1

1296

6880

Z01.8

ICD-10 Finland

Other specified special examinations

1.6

103.9

3275

22532

A41.9

ICD-10 Finland

Sepsis, unspecified

2.4

103.0

735

3135

N05CD07

ATC

temazepam; oral

1.7

102.4

2147

13350

A07EA06

ATC

budesonide; oral, local oral

2.7

102.3

558

2091

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.6

102.2

2769

18376

XF600

NOMESCO Finland

Bloodpressure measurement

2.1

102.2

1090

5476

I10

ICD-10 Finland

Essential (primary) hypertension

1.4

101.8

9806

83683

Z94.4

ICD-10 Finland

Liver transplant status

10.1

101.6

115

N18.8

ICD-10 Finland

Other chronic renal failure

2.7

101.3

558

2102

L28

ICPC

Limited function/disability (L)

1.6

101.2

2980

20167

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.5

100.7

3687

26193

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.5

99.8

3913

28196

JJC00

NOMESCO Finland

Allogenic transplantation of liver

13.5

99.6

F10.49

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without information about seizures

6.2

99.3

171

280

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.2

99.2

923

4401

I84.1

ICD-10 Finland

Internal hemorrhoids with other complications

3.1

99.1

425

1396

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.3

99.1

749

3276

B03XA02

ATC

darbepoetin alfa; parenteral

3.1

99.0

431

1428

C08CA01

ATC

amlodipine; oral

1.4

98.9

6208

48977

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.0

98.1

1114

5722

WX882

NOMESCO Finland

High dependency care

2.7

97.9

537

2018

ZXD10

NOMESCO Finland

Scheduled procedure

1.4

97.9

5619

43587

E86

ICD-10 Finland

Volume depletion

2.7

97.4

549

2092

127

Kela drug reimbursment

Transplant complication

3.9

97.3

293

767

103

Kela drug reimbursment

Diabetes, insulin-treated

1.5

97.0

4479

33322

Z72.1

ICD-10 Finland

Alcohol use

4.2

96.9

258

617

I86.4

ICD-10 Finland

Gastric varices

28.4

96.8

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

3.0

96.4

431

1450

UJH02

NOMESCO Finland

Anoscopy

2.5

95.6

653

2729

A12AA04

ATC

calcium carbonate; oral

3.5

95.6

338

986

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.9

95.6

1213

6474

A10AE04

ATC

insulin glargine; parenteral

1.8

95.4

1592

9268

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.2

94.7

808

3719

WX872

NOMESCO Finland

Intensive care

2.1

94.6

904

4353

R04.0

ICD-10 Finland

Epistaxis

1.9

94.5

1367

7616

K50.8

ICD-10 Finland

Other Crohn disease

4.2

94.3

253

609

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

3.5

94.2

326

938

D01

ICPC

Abdominal pain/cramps general

1.8

93.1

1532

8879

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.7

92.9

2092

13230

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.1

92.8

950

4695

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.4

92.6

647

2732

SPAT1262

SPAT

Handing over of treatment supplies

1.6

92.4

2803

19054

K90.3

ICD-10 Finland

Pancreatic steatorrhoea

12.2

92.3

N06AB10

ATC

escitalopram; oral

1.6

91.8

2439

16068

D14

ICPC

Haematemesis/vomiting blood

16.0

91.4

K86.1

ICD-10 Finland

Other chronic pancreatitis

4.8

91.1

204

425

S97

ICPC

Chronic ulcer skin

2.0

90.9

1090

5702

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

4.7

90.9

210

449

S06.0

ICD-10 Finland

Concussion

1.8

90.5

1637

9749

JDA52

NOMESCO Finland

Other endoscopic procedure using diathermy or heat in stomach or pylorus

9.7

90.3

105

109

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.7

90.3

494

1854

A02BD07

ATC

lansoprazole, amoxicillin and clarithromycin; systemic

2.2

89.7

790

3682

EBA15

NOMESCO Finland

Extraction of multiple teeth

2.3

89.6

703

3124

JDA35

NOMESCO Finland

Endoscopic contact coagulation in stomach or pylorus

12.7

89.5

K59.09

ICD-10 Finland

Constipation, unspecified

1.9

89.4

1130

6018

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.3

89.3

677

2964

N05BA02

ATC

chlordiazepoxide; systemic

2.9

89.2

440

1564

R60.0

ICD-10 Finland

Localized oedema

1.7

88.8

1965

12357

R10.0

ICD-10 Finland

Acute abdomen

2.6

88.4

530

2082

M54.5

ICD-10 Finland

Low back pain

1.4

87.9

4657

35425

A07EA02

ATC

hydrocortisone; rectal

3.1

87.7

372

1214

C01DA14

ATC

isosorbide mononitrate; oral

1.5

87.4

3202

22652

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.1

86.7

895

4435

N03AX12

ATC

[U] gabapentin; oral

1.6

86.6

2274

14921

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.5

86.2

3721

27204

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

4.0

86.0

247

625

N19

ICD-10 Finland

Unspecified kidney failure

2.2

85.8

731

3361

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.8

85.7

1473

8636

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.9

85.6

1197

6589

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

3.2

85.5

353

1134

R42

ICD-10 Finland

Dizziness and giddiness

1.5

85.4

3545

25709

K50.1

ICD-10 Finland

Crohn disease of large intestine

4.5

84.3

208

469

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.5

84.0

546

2229

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.6

83.9

2524

17083

K29.8

ICD-10 Finland

Duodenitis

4.5

83.9

204

455

B01AC04

ATC

clopidogrel; oral

1.5

83.5

2918

20411

1300

FHL

Esophagogastroduodenoscopy (also includes staining)

3.9

83.5

245

630

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.9

83.1

1160

6380

R4190

NOMESCO Finland

Nutritional therapy

2.5

83.1

534

2169

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

4.0

82.8

239

607

K50.0

ICD-10 Finland

Crohn disease of small intestine

3.9

82.8

243

625

M10.9

ICD-10 Finland

Gout, unspecified

1.8

82.6

1273

7221

SPAT1265

SPAT

Breathalyser

4.8

82.5

185

386

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.5

82.5

3661

26873

K51.8

ICD-10 Finland

Other ulcerative colitis

3.9

82.2

243

628

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.5

82.2

537

2198

K85.2

ICD-10 Finland

Alcohol-induced acute pancreatitis

6.4

81.8

135

212

K86.3

ICD-10 Finland

Pseudocyst of pancreas

6.4

81.4

135

213

M79.6

ICD-10 Finland

Pain in limb

1.4

81.2

5521

43744

N30.0

ICD-10 Finland

Acute cystitis

1.6

81.1

2204

14562

JJ9AE

NOMESCO Finland

Ultrasound examination of liver transplant

14.0

80.8

E87.5

ICD-10 Finland

Hyperkalaemia

2.9

80.4

394

1395

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.3

80.4

643

2879

A07AA09

ATC

vancomycin; oral

3.4

80.2

294

878

N02AJ06

ATC

codeine and paracetamol; systemic

1.4

79.8

5522

43845

K55.0

ICD-10 Finland

Acute vascular disorders of intestine

4.5

79.3

195

439

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

79.2

2589

17829

G31.2

ICD-10 Finland

Degeneration of nervous system due to alcohol

4.8

79.0

177

369

PC1CC

NOMESCO Finland

Very extensive angiography of aorta and abdominal arteries

7.9

78.9

108

138

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

2.6

78.7

487

1942

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.5

78.7

2857

20116

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

3.7

78.5

254

699

W19

ICD-10 Finland

Unspecified fall

1.7

78.5

1564

9548

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

2.7

78.3

416

1538

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

78.1

6890

56842

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

78.1

2578

17787

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.2

78.0

706

3324

R58

ICD-10 Finland

Haemorrhage, not elsewhere classified

3.3

77.8

300

925

L04AA06

ATC

mycophenolic acid; systemic

3.2

77.7

309

971

207

Kela drug reimbursment

Chronic arrhythmias

1.5

77.7

2816

19816

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.1

77.4

747

3607

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.0

77.1

913

4750

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.3

76.9

591

2601

Z51.5

ICD-10 Finland

Palliative care

1.7

76.8

1400

8337

UJG02

NOMESCO Finland

Proctoscopy

2.8

76.5

392

1422

N06AB03

ATC

fluoxetine; oral

1.7

76.4

1554

9535

UKC02

NOMESCO Finland

Cystoscopy

1.5

76.4

2836

20045

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

3.0

76.3

345

1168

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.6

76.1

1888

12190

WVA20

NOMESCO Finland

Medicine administration

2.6

76.0

444

1722

UJF12

NOMESCO Finland

Enteroscopy through intestinal stoma

8.6

75.9

114

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.5

75.8

2513

17341

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.5

75.8

474

1900

R03AC02

ATC

salbutamol; inhalant

1.4

75.6

7336

61315

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

75.6

5439

43361

J01DA01

ATC

[U] cefalexin

1.4

75.5

8827

75919

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.8

75.4

1242

7180

R55

ICD-10 Finland

Syncope and collapse

1.6

75.4

1884

12185

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

1.9

75.3

1021

5557

N18.0

ICD-10 Finland

End-stage renal disease

3.6

75.3

251

705

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

2.1

74.9

729

3531

I35.0

ICD-10 Finland

Aortic (valve) stenosis

1.8

74.9

1205

6919

F10.03

ICD-10 Finland

Alcohol-related acute intoxication with delirium

6.9

74.6

114

165

A01

ICPC

Pain general/multiple sites

1.8

74.5

1317

7771

T90

ICPC

Diabetes non-insulin dependent

1.4

74.5

3632

27054

205

Kela drug reimbursment

Chronic hypertension

1.4

74.5

4782

37391

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.4

74.4

4151

31681

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

2.6

74.3

459

1829

R31

ICD-10 Finland

Unspecified haematuria

1.6

74.0

1857

12018

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

3.5

73.9

262

766

R02

ICPC

Shortness of breath/dyspnoea

1.6

73.9

1928

12595

N06AX21

ATC

duloxetine; oral

1.7

73.4

1426

8638

SPAT1249

SPAT

Treatment-related counselling outside office

1.4

73.0

5367

42872

WX110

NOMESCO Finland

Infiltration anesthesia

1.4

73.0

9514

82982

JDH15

NOMESCO Finland

Endoscopic injection in duodenum

26.4

72.5

N05AH03

ATC

olanzapine; systemic

2.0

72.1

787

3976

R33

ICD-10 Finland

Retention of urine

1.7

72.1

1551

9652

PG1PT

NOMESCO Finland

Extensive endovascular embolisation for bleeding with radiological guidance not elsewhere classified

5.3

72.0

144

272

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

3.4

71.9

261

775

D12.8

ICD-10 Finland

Benign neoplasm: Rectum

2.1

71.8

676

3232

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

6.1

71.8

124

204

K83.0

ICD-10 Finland

Cholangitis

3.2

71.5

289

917

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

1.9

71.4

1028

5703

R04.2

ICD-10 Finland

Haemoptysis

2.2

71.3

639

2996

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.0

71.3

779

3938

B02AA02

ATC

tranexamic acid; systemic

1.7

71.2

1538

9579

I81

ICD-10 Finland

Portal vein thrombosis

6.4

71.2

117

183

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.9

70.9

972

5308

PD1BD

NOMESCO Finland

Extensive CT of abdominal aorta and branches

3.9

70.7

211

549

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

3.1

70.4

304

1003

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.0

70.4

854

4478

JDA22

NOMESCO Finland

Endoscopic ligature of varices of stomach

17.1

70.3

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.4

70.1

4313

33407

R03BB04

ATC

tiotropium bromide; inhalant

1.6

70.1

1719

11055

K70.0

ICD-10 Finland

Alcoholic fatty liver

4.5

70.0

172

387

K26.7

ICD-10 Finland

Duodenal ulcer, chronic without haemorrhage or perforation

6.4

69.2

115

182

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

2.7

69.1

377

1413

E13.9

ICD-10 Finland

Other specified diabetes mellitus, without complications

4.0

69.0

194

484

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

3.9

68.7

203

525

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.6

68.4

1813

11875

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

2.8

68.1

352

1283

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.7

67.7

1217

7209

SPAT1260

SPAT

Consultation of another employee

1.5

67.6

2507

17669

N17.8

ICD-10 Finland

Other acute renal failure

3.3

67.6

257

786

K91.4

ICD-10 Finland

Colostomy and enterostomy malfunction

230.9

67.3

JAH01

NOMESCO Finland

Laparoscopy

2.3

66.8

546

2466

D13.1

ICD-10 Finland

Benign neoplasm: Stomach

2.7

66.5

373

1417

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.8

66.5

1045

5951

N06AB06

ATC

sertraline; oral

1.7

66.3

1309

7956

Z71.8

ICD-10 Finland

Other specified counselling

1.4

66.3

3833

29329

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.0

66.2

715

3597

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.6

66.2

1569

9996

S18

ICPC

Laceration/cut

1.3

66.2

6485

53902

J45.9

ICD-10 Finland

Asthma, unspecified

1.5

66.1

2544

18056

C07AB02

ATC

metoprolol; systemic

1.4

65.1

3439

25895

C07AG02

ATC

carvedilol; oral

1.8

65.0

1019

5797

K29.1

ICD-10 Finland

Other acute gastritis

3.4

65.0

238

711

K65.0

ICD-10 Finland

Acute peritonitis

3.4

64.9

241

726

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.6

64.8

1544

9847

Z09.8

ICD-10 Finland

Follow-up examination after other treatment for other conditions

2.5

64.7

427

1756

PD1CD

NOMESCO Finland

Very extensive CT of abdominal aorta and branches

6.2

64.4

110

179

AN1

Coronary angiography

1.5

64.4

1961

13245

C22.0

ICD-10 Finland

Malignant neoplasm: Liver cell carcinoma

3.8

64.3

200

536

I84.9

ICD-10 Finland

Unspecified hemorrhoids without complication

2.0

63.9

681

3409

D11

ICPC

Diarrhoea

1.7

63.9

1373

8531

D12.2

ICD-10 Finland

Benign neoplasm: Ascending colon

2.2

63.7

544

2502

UJF14

NOMESCO Finland

Enteroscopy of ileoanal anastomosis

6.6

63.4

102

156

SPAT1240

SPAT

Therapeutic discussion

1.7

63.0

1118

6593

WZC30

NOMESCO Finland

Teaching

1.5

62.7

2126

14688

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.5

62.7

2512

17952

EBA00

NOMESCO Finland

Extraction of tooth

1.4

62.6

4643

36924

J01CA04

ATC

amoxicillin; systemic

1.4

62.4

11471

103967

J01MA14

ATC

moxifloxacin; systemic

1.7

62.2

1291

7945

C09AA05

ATC

ramipril; oral

1.4

62.1

4107

32069

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.7

62.1

1358

8473

A41.8

ICD-10 Finland

Other specified sepsis

2.6

61.4

356

1376

130

Kela drug reimbursment

Malignant tumour

1.6

61.3

1416

8958

N05CF02

ATC

zolpidem; oral

1.5

61.1

2099

14535

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

2.1

60.8

611

2994

V03AE01

ATC

polystyrene sulfonate; oral

3.0

60.7

267

891

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

1.9

60.6

854

4699

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.7

60.4

1268

7825

C05AA08

ATC

fluocortolone; rectal, topical

1.5

60.4

1853

12523

PD1AD

NOMESCO Finland

CT of abdominal aorta and branches

4.1

60.3

166

408

K76.7

ICD-10 Finland

Hepatorenal syndrome

9.6

60.0

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.0

60.0

701

3626

ZXA00

NOMESCO Finland

Right side

1.4

59.9

3895

30297

X58

ICD-10 Finland

Exposure to other specified factors

1.5

59.6

1775

11916

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.7

59.5

1125

6752

K56.7

ICD-10 Finland

Ileus, unspecified

2.7

59.5

326

1225

326

Kela drug reimbursment

Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)

4.6

59.1

141

310

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

4.0

59.0

167

419

N03AX09

ATC

lamotrigine; oral

2.2

58.9

517

2403

WX730

NOMESCO Finland

Conventional respirator

2.8

58.8

294

1053

K59.1

ICD-10 Finland

Functional diarrhoea

1.9

58.6

759

4064

V03AA01, ,

ATC

2.9

58.5

271

931

A10BA02

ATC

metformin; oral

1.4

58.3

4386

34875

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.0

58.2

692

3601

WX704

NOMESCO Finland

Intubation

1.7

58.1

1053

6244

N05AX12

ATC

aripiprazole; systemic

2.4

57.9

405

1710

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

4.0

57.9

165

416

N05AF03

ATC

chlorprothixene; systemic

2.6

57.9

344

1346

K59.0

ICD-10 Finland

Constipation

1.8

57.7

901

5117

K72.1

ICD-10 Finland

Chronic hepatic failure

9.9

57.7

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

2.9

57.6

266

912

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

2.0

57.5

615

3082

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

1.9

57.5

795

4348

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

2.0

57.3

622

3134

D37.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Stomach

3.9

57.3

167

428

UJK02

NOMESCO Finland

ERCP

2.3

57.0

442

1952

K85

ICD-10 Finland

Acute pancreatitis

2.8

56.9

299

1099

JKE98

NOMESCO Finland

Other transduodenal endoscopic operation on bile duct or ampulla of Vater

2.8

56.9

287

1033

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.6

56.6

340

1337

A10AC01

ATC

insulin (human); parenteral

1.7

56.4

1186

7320

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.3

56.3

445

1982

K51.1

ICD-10 Finland

Ulcerative (chronic) ileocolitis

4.1

56.2

154

377

K51.0

ICD-10 Finland

Ulcerative (chronic) pancolitis

4.4

56.2

141

323

JF1CG

NOMESCO Finland

Extensive MRI of small bowel

5.3

56.0

112

212

SPAT1229

SPAT

Assessment of need for aid

1.6

55.7

1245

7803

T74.1

ICD-10 Finland

Physical abuse

3.3

55.6

216

670

S22.3

ICD-10 Finland

Fracture of rib

1.7

55.5

1057

6351

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

2.8

55.5

275

980

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.0

55.4

655

3400

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

2.7

55.4

313

1194

SPAT1216

SPAT

Assessment of functional ability

1.4

55.2

2465

17941

R07.3

ICD-10 Finland

Other chest pain

1.6

55.1

1395

9012

C09AA02

ATC

enalapril; systemic

1.4

55.1

3179

24201

Z49.0

ICD-10 Finland

Preparatory care for dialysis

3.5

54.9

189

543

L04AD02

ATC

tacrolimus; systemic

3.9

54.6

163

425

E0000UV, ,

ATC

1.3

54.5

5484

45382

R13

ICD-10 Finland

Dysphagia

1.7

54.2

1000

5958

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.7

54.1

1011

6043

D12.0

ICD-10 Finland

Benign neoplasm: Caecum

2.3

54.0

416

1833

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.1

53.9

541

2648

Z93.3

ICD-10 Finland

Colostomy status

3.9

53.9

161

420

D10

ICPC

Vomiting

2.0

53.8

602

3065

1370

FHL

Colonoscopy, whole colon

4.7

53.8

125

269

F10.01

ICD-10 Finland

Alcohol-related acute intoxication with permanent or other somatic damage

4.6

53.8

126

273

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.8

53.7

848

4829

X57

ICD-10 Finland

Unspecified privation

2.4

53.7

363

1509

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

3.4

53.6

196

585

RD210, ,

NOMESCO Finland

2.9

53.6

256

895

ZJX00

NOMESCO Finland

Double balloon technique in gastroenterological endoscopy

14.6

53.6

N05BE01

ATC

buspirone; oral

2.4

53.4

392

1691

K86.01

ICD-10 Finland

Late effects of pancreatitis caused by alcohol

8.3

53.4

F10.06

ICD-10 Finland

Alcohol-related acute intoxication with seizures

11.8

53.1

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.7

53.0

1126

6962

B18.2

ICD-10 Finland

Chronic viral hepatitis C

3.9

52.9

153

390

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.3

52.9

3883

30679

A10BH01

ATC

sitagliptin; oral

1.6

52.9

1438

9445

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

5.6

52.8

100

180

G44.2

ICD-10 Finland

Tension-type headache

1.6

52.6

1513

10065

K29.9

ICD-10 Finland

Gastroduodenitis, unspecified

3.6

52.5

175

492

K22.7

ICD-10 Finland

Barrett oesophagus

3.0

52.4

228

756

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.6

52.2

1226

7775

E66.00

ICD-10 Finland

Metabolic syndrome

1.9

52.2

707

3841

S01.0

ICD-10 Finland

Open wound of scalp

1.6

52.0

1236

7862

S42.2

ICD-10 Finland

Fracture of upper end of humerus

1.9

51.8

693

3748

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.8

51.8

858

4956

PC4SC

NOMESCO Finland

Bowel angiography with X-ray

9.7

51.8

D37.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Small intestine

4.7

51.8

120

258

F10.41

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol with seizures

7.7

51.7

P03

ICPC

Feeling depressed

1.7

51.6

949

5645

N06AA09

ATC

amitriptyline; systemic

1.6

51.4

1279

8225

F10.3

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Withdrawal state

6.1

51.4

147

L04AD01

ATC

ciclosporin; systemic

2.8

51.2

260

939

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.7

51.2

1041

6363

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

2.4

51.0

350

1465

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

2.3

50.9

408

1827

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.9

50.9

690

3749

B01AF02

ATC

apixaban; oral

1.5

50.9

2027

14421

D13.2

ICD-10 Finland

Benign neoplasm: Duodenum

4.1

50.7

140

345

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

1.7

50.7

1069

6596

F10.23

ICD-10 Finland

Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication

5.2

50.6

103

198

C10AC01

ATC

colestyramine; oral

2.4

50.6

357

1514

Z02.7

ICD-10 Finland

Issue of medical certificate

1.7

50.5

993

6015

K23.8*B37.8

ICD-10 Finland

Esophagitis caused by candidiasis

4.7

50.4

115

244

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

1.8

50.4

860

5010

K51.3

ICD-10 Finland

Ulcerative (chronic) rectosigmoiditis

2.8

50.3

255

920

N06AA12

ATC

doxepin; systemic

1.8

50.1

748

4187

D50

ICD-10 Finland

Iron deficiency anaemia

2.6

50.0

300

1180

A10AE05

ATC

insulin detemir; parenteral

1.8

49.9

766

4325

A29

ICPC

General symptom/complaint other

1.5

49.8

1779

12381

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.8

49.7

846

4924

K51.2

ICD-10 Finland

Ulcerative (chronic) proctitis

3.1

49.6

213

701

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

1.7

49.6

882

5197

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.5

49.4

1829

12820

SPAT1247

SPAT

Outpatient detoxication and monitoring

5.4

49.4

177

K72.0

ICD-10 Finland

Acute and subacute hepatic failure

5.4

49.4

177

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.6

49.3

1361

8962

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

3.0

49.0

216

722

B01AB04

ATC

dalteparin; parenteral

1.8

48.9

764

4337

SPAT1104

SPAT

Monitoring of emergency patient

1.7

48.5

954

5778

TK810

NOMESCO Finland

Hemofiltration

4.1

48.4

131

318

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

1.7

48.4

1051

6532

ZXA05

NOMESCO Finland

Left side

1.3

48.3

3598

28421

R63.8

ICD-10 Finland

Other symptoms and signs concerning food and fluid intake

6.6

48.2

117

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

2.6

48.2

273

1044

E13.8

ICD-10 Finland

Other specified diabetes mellitus, with unspecified complications

8.0

48.0

N05BA12

ATC

alprazolam; oral

1.6

47.8

1231

7975

F60.9

ICD-10 Finland

Personality disorder, unspecified

3.6

47.8

159

447

I95.9

ICD-10 Finland

Hypotension, unspecified

2.6

47.7

285

1118

F05.9

ICD-10 Finland

Delirium, unspecified

2.2

47.7

397

1806

K30

ICD-10 Finland

Functional dyspepsia

1.6

47.6

1312

8634

N06AX03

ATC

mianserin; oral

1.9

47.5

644

3497

N05AB01

ATC

dixyrazine; systemic

3.1

47.4

204

673

O99.6

ICD-10 Finland

Diseases of the digestive system complicating pregnancy, childbirth and the puerperium

6.7

47.4

113

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.3

47.3

3637

28847

K76.6

ICD-10 Finland

Portal hypertension

18.1

47.3

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

2.1

47.2

433

2049

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.2

47.1

401

1841

JL5SB

NOMESCO Finland

Endoscopic retrograd cholangiopancreaticography

2.6

47.1

268

1027

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

6.1

47.1

133

D18

ICPC

Change in faeces/bowel movements

2.3

47.0

356

1557

J01EA01

ATC

trimethoprim; systemic

1.3

47.0

3402

26743

XW000

NOMESCO Finland

Bone marrow biopsy

1.9

47.0

613

3289

N03AG01

ATC

valproic acid; systemic, rectal

1.8

46.9

746

4255

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

4.4

46.9

118

271

E66.01

ICD-10 Finland

Obesity due to excess calories

1.7

46.9

875

5225

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.5

46.8

1819

12862

RS221, ,

NOMESCO Finland

2.9

46.8

222

773

K31.8

ICD-10 Finland

Other specified diseases of stomach and duodenum

4.2

46.6

122

289

H02AB07

ATC

prednisone; oral

1.5

46.6

1898

13545

ZXE40

NOMESCO Finland

More than seven and less than nine hours

2.3

46.5

354

1552

D97

ICPC

Liver disease NOS

4.9

46.4

102

210

N03AE01

ATC

clonazepam; systemic

1.8

46.3

752

4318

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.6

46.2

1032

6457

B03BA03

ATC

hydroxocobalamin; parenteral

1.7

46.1

941

5753

L17

ICPC

Foot/toe symptom/complaint

1.3

46.1

3719

29685

K29.6

ICD-10 Finland

Other gastritis

3.0

45.9

199

659

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

4.0

45.7

128

319

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.4

45.6

1952

14053

R60.9

ICD-10 Finland

Oedema, unspecified

1.8

45.6

782

4559

SPAT1252

SPAT

Overall medication plan or its review

1.6

45.5

1061

6709

P76

ICPC

Depressive disorder

1.9

45.4

625

3411

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

1.6

45.3

1083

6892

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.1

45.1

415

1966

Z72.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

8498

59949

1.88

323.31

10.4

5.9

1.20

1.21

mmol/l

54.75

7925

54161

(3022145) Colonoscopy Study observation

2741

12970

2.34

317.22

1.5

1.3

—

(3019198) Lymphocytes [#/volume] in Blood

8823

63326

1.86

314.30

7.8

5.7

1.77

1.92

e9/l

6.41

7924

55255

(3002173) Hemoglobin [Mass/volume] in Arterial blood

2731

12973

2.33

312.85

10.1

7.5

113.72

121.94

g/l

69.28

2687

12599

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

2858

11648

2.76

307.65

3.2

2.1

0.19

0.21

g/l

25.78

2614

10747

(3012095) Magnesium [Moles/volume] in Serum or Plasma

4204

21135

2.33

307.65

4.7

3.2

0.80

0.82

mmol/l

24.24

3933

19590

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

2548

11298

2.49

307.65

3.5

2.4

47.05

49.94

u/l

0.11

2238

9618

(3018677) aPTT in Platelet poor plasma by Coagulation assay

3897

20958

2.13

307.65

3.1

2.1

30.87

30.02

10.24

3782

20336

(3027801) Oxygen [Partial pressure] in Arterial blood

3236

16013

2.27

307.65

9.4

6.7

11.61

12.01

kpa

4.84

3098

15151

(3003396) Base excess in Arterial blood by calculation

3244

16016

2.28

307.65

9.3

6.7

1.03

1.04

mmol/l

0.03

2577

12591

(3000991) Gas panel - Venous blood

2626

11549

2.52

307.65

10.9

7.8

—

(3016502) Oxygen saturation in Arterial blood

3007

14345

2.34

307.65

9.6

7.1

95.21

95.39

0.66

2916

13763

(3023368) Bacteria identified in Blood by Culture

6702

38975

2.22

307.65

6.1

4.2

—

(3022217) INR in Platelet poor plasma by Coagulation assay

10105

64879

2.48

307.65

23.3

17.9

1.33

1.36

inr

1.01

3139

18150

(3003458) Phosphate [Moles/volume] in Serum or Plasma

3674

17595

2.41

307.65

8.6

5.6

1.07

1.04

mmol/l

5.56

3453

16173

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

7494

39288

2.68

307.65

3.9

2.5

67.19

64.26

u/l

0.14

7134

36069

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

3095

13969

2.50

307.65

4.5

2.7

11.82

9.22

umol/l

4.17

2734

12114

(3012544) pH of Venous blood

3083

13622

2.56

307.65

5.8

3.8

7.36

7.38

0.88

(3024354) Oxygen [Partial pressure] in Venous blood

2484

10845

2.52

307.65

5.1

3.3

4.56

4.50

kpa

0.69

2391

10456

(3022948) Iron [Moles/volume] in Serum or Plasma

4699

21227

2.71

307.65

3.6

2.4

10.91

12.65

umol/l

41.56

4425

19533

(3001604) Monocytes [#/volume] in Blood

8695

61637

1.88

307.65

7.7

5.6

0.64

0.62

e9/l

9.44

7672

52597

(3023183) Ammonium ion [Moles/volume] in Plasma

1149

2598

4.68

307.65

4.7

2.3

39.24

32.25

umol/l

12.28

1062

2287

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

9314

65973

1.97

307.65

11.2

6.6

1.20

1.21

mmol/l

51.27

8052

55504

(3013826) Glucose [Moles/volume] in Serum or Plasma

10451

76877

2.01

307.65

8.4

4.7

6.99

6.84

mmol/l

9.16

10090

72084

(40768797) Stomach Pathology biopsy report

3941

15731

2.99

307.65

1.5

1.2

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

6732

34069

2.67

307.65

3.3

2.2

3.51

3.02

mg/l

33.49

5988

28696

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

4215

18524

2.72

307.65

3.8

2.5

19.59

22.32

23.08

3660

15585

(3021447) Carbon dioxide [Partial pressure] in Venous blood

3016

13166

2.58

307.65

5.8

3.8

5.77

5.84

kpa

2.72

2916

12767

(3024561) Albumin [Mass/volume] in Serum or Plasma

8953

56823

2.28

307.65

8.2

4.6

33.41

34.92

g/l

101.05

8452

52233

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

9006

58192

2.23

307.65

4.1

2.6

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

8115

50586

2.21

307.65

4.5

2.8

137.51

151.66

ug/l

3.40

7504

46005

(40760892) CBC W Ordered Manual Differential panel - Blood

8298

57780

1.89

307.65

8.4

6.3

—

(3027945) Reticulocytes/100 erythrocytes in Blood

3552

16414

2.49

307.65

2.9

2.4

2.03

1.73

35.77

3158

14312

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

6288

38299

2.05

307.65

5.0

3.1

38.49

35.25

u/l

1.88

5954

36016

(3013650) Neutrophils [#/volume] in Blood by Automated count

9919

71261

2.01

307.65

11.7

8.6

4.54

4.28

e9/l

16.17

8900

61542

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

3239

16023

2.28

307.65

9.4

6.7

4.99

5.07

kpa

4.85

3100

15181

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

5503

30600

2.21

307.65

3.9

2.3

—

(3020779) Urea [Moles/volume] in Serum or Plasma

2868

12502

2.57

307.65

10.5

6.7

11.77

10.74

mmol/l

8.16

2719

11757

(3002032) Base excess in Venous blood by calculation

2987

13157

2.56

307.65

5.9

3.8

1.62

1.88

mmol/l

3.08

2504

11066

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

2547

9575

2.97

307.65

2.1

1.6

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

3703

17151

2.50

307.65

9.5

6.7

104.34

104.44

mmol/l

0.57

3697

17138

(3006315) Basophils [#/volume] in Blood

8717

61829

1.88

307.65

7.7

5.6

0.04

e9/l

0.25

7702

52765

(3013115) Eosinophils [#/volume] in Blood

8910

63765

1.88

307.65

8.0

5.9

0.19

0.20

e9/l

1.32

7935

55123

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

10474

66070

2.65

307.65

9.6

5.9

12.98

12.31

umol/l

2.76

10088

62450

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

12284

96908

2.10

307.65

12.6

7.3

87.76

80.13

u/l

30.82

11844

90714

(3014111) Lactate [Moles/volume] in Serum or Plasma

2737

12106

2.52

307.65

8.6

6.5

1.50

1.39

mmol/l

3.57

2670

11723

(3004789) Transferrin [Mass/volume] in Serum or Plasma

4442

19637

2.74

307.65

3.6

2.4

2.31

2.27

g/l

3.27

4155

17998

(3023520) Reticulocytes [#/volume] in Blood

2698

12259

2.44

307.65

2.9

2.5

74.98

67.69

e9/l

15.24

2080

9303

(3044640) Blood type and Crossmatch panel - Blood

7089

40201

2.35

307.65

4.0

2.4

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

1717

6603

2.79

306.85

1.8

1.6

1.47

1.56

g/l

3.63

1489

5580

(3033658) Prothrombin time (PT) actual/Normal

5277

32338

1.94

306.51

8.0

3.9

81.76

85.75

22.00

5144

31563

(3019069) Monocytes/100 leukocytes in Blood

8246

58409

1.84

301.80

8.4

6.2

9.00

8.78

7.06

7789

54172

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

4086

23080

2.03

299.25

2.2

1.8

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

3136

16049

2.18

298.50

4.2

4.0

245.04

248.87

u/l

0.64

2954

15046

(3006504) Eosinophils/100 leukocytes in Blood

8190

58066

1.83

297.12

8.1

5.9

2.76

2.85

2.90

7725

53788

(3022096) Basophils/100 leukocytes in Blood

7998

56300

1.83

297.05

8.0

5.9

0.64

0.65

0.93

7543

52083

(3026008) Bacteria identified in Urine by Culture

6207

40733

1.85

286.89

4.1

3.3

—

(3002030) Lymphocytes/100 leukocytes in Blood

8330

59796

1.81

285.81

8.2

6.0

24.46

26.69

60.70

7875

55603

(3018010) Neutrophils/100 leukocytes in Blood

8193

58762

1.80

279.62

7.9

5.8

59.86

58.13

30.73

7741

54604

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1074

3364

3.35

274.10

3.7

2.7

3.29

3.63

g/l

9.53

1015

3196

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1639

6672

2.62

259.98

6.6

4.1

23.76

24.06

mmol/l

2.99

1602

6508

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

7351

51826

1.76

259.20

5.6

3.9

51.69

81.56

ng/l

1.59

5789

38419

(3002582) Erythrocytes [#/volume] in Urine

6155

41325

1.79

256.02

4.4

3.4

76.62

111.38

e6/l

1.02

5045

31940

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

2672

13652

2.15

251.25

4.0

3.9

22.11

25.27

ug/l

0.22

2240

11287

(3042936) Bacteria identified in Isolate by Culture

3333

18615

1.99

245.48

2.7

2.0

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

1878

8371

2.41

244.74

4.9

3.4

117.99

129.17

g/l

67.22

1833

8163

(3031040) Bacteria [#/volume] in Urine by Automated count

10693

84609

1.77

244.47

6.4

4.7

1092.05

1454.08

e6/l

0.39

191

1388

(3021960) Folate [Moles/volume] in Serum or Plasma

4998

31886

1.82

244.13

1.8

1.6

19.76

19.88

nmol/l

0.21

4439

27080

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2959

15870

2.06

243.91

2.2

1.8

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2954

15876

2.05

241.92

2.1

1.8

—

(3019309) Folate [Moles/volume] in Red Blood Cells

4485

27844

1.84

238.41

2.0

1.8

1235.13

1154.90

nmol/l

5.95

3497

20664

(3026782) Osmolality of Urine

4457

27730

1.84

234.60

4.0

3.0

523.64

552.09

mosm/kgh2o

15.30

3950

23747

(3014007) Fractional oxyhemoglobin in Arterial blood

1887

8620

2.34

231.92

11.3

8.5

93.20

93.84

3.15

1876

8586

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1131

4038

2.93

229.92

1.4

1.3

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1539

6456

2.53

228.13

4.0

2.8

1.35

1.22

4.61

1534

6422

(3030467) Casts [#/volume] in Urine by Automated count

5626

37763

1.75

227.38

4.3

3.3

0.55

0.46

e6/l

1.54

4608

29013

(3048689) Calprotectin [Mass/mass] in Stool

2428

12493

2.11

221.85

3.4

2.2

211.73

146.87

ug/g

8.08

2038

9768

(3018095) Leukocytes [#/volume] in Urine

6650

47035

1.70

220.30

5.1

3.8

135.49

107.99

e6/l

1.05

5255

34013

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

1862

8636

2.31

220.27

11.3

8.5

0.67

0.05

1847

8573

(3000850) Epithelial cells [#/volume] in Urine

4549

28936

1.79

219.94

3.4

2.7

5.33

4.81

e6/l

2.02

4167

25900

(3018418) pH of Serum or Plasma

5720

38866

1.73

219.38

6.3

4.0

7.40

0.56

1177

7381

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

7531

55141

1.68

218.30

2.4

2.0

91.51

93.74

pmol/l

3.46

4375

29229

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1856

8655

2.29

216.57

11.2

8.3

1.46

1.36

4.25

1842

8591

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

1493

6324

2.50

216.35

4.0

2.8

0.69

0.65

3.32

1488

6296

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

6074

42250

1.70

211.81

4.0

3.1

2378.42

1746.37

ng/l

11.91

5345

36458

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1266

5023

2.65

209.90

4.4

3.0

0.30

0.36

u/ml

7.26

761

2844

(36304419) Bacteria [Presence] in Urine

5371

36320

1.71

206.68

4.3

3.2

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

605

1591

3.91

200.06

3.0

2.6

2184.69

736.38

u/ml

0.45

590

1571

(3017143) Hepatitis C virus Ab [Presence] in Serum

2226

11529

2.08

198.18

1.9

1.6

—

(3007853) Bacteria identified in Skin by Aerobe culture

2732

15277

1.95

195.72

2.2

1.8

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

5806

40530

1.67

195.66

2.6

2.1

236.11

231.08

u/l

0.13

5503

37828

(3007566) Smooth muscle Ab [Titer] in Serum

852

2844

3.11

194.38

1.4

1.2

86.97

141.20

titre

1.22

241

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

4154

26630

1.75

190.69

5.5

4.0

405.96

503.74

ng/l

0.58

3468

22175

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

2331

12442

2.02

190.49

2.5

1.7

1.74

1.51

25.69

1967

10696

(3034770) Mitochondria Ab [Titer] in Serum

839

2840

3.06

186.73

1.3

1.2

618.00

887.36

titre

0.62

(40758558) Short blood count panel - Blood

4686

31266

1.70

185.11

9.1

6.7

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1726

8307

2.21

185.02

10.5

7.1

24.50

24.75

mmol/l

1.85

1716

8213

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

4104

26440

1.74

184.03

2.6

1.7

1.41

mg/l

0.06

3275

20367

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1709

8225

2.20

183.11

1.7

1.5

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1578

7352

2.27

183.01

12.7

9.2

—

(3019060) Gas panel - Arterial blood

1892

9483

2.13

182.79

6.6

4.5

—

(3037467) Urinalysis macro (dipstick) panel - Urine

10649

87311

1.64

181.65

6.0

4.4

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

1787

8827

2.15

179.08

9.5

6.6

24.14

24.58

mmol/l

4.25

1724

8385

(3027273) Bicarbonate [Moles/volume] in Venous blood

1489

6905

2.27

174.27

4.9

3.4

24.77

25.17

mmol/l

3.84

1448

6698

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

9500

76358

1.59

170.36

5.5

3.0

77.62

52.15

u/l

53.01

8901

70003

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1394

6361

2.30

169.33

5.7

4.1

47.11

47.37

0.14

1381

6285

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

923

3482

2.75

168.12

3.7

2.6

86.80

89.83

2.84

889

3352

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

2430

13764

1.90

164.92

1.9

1.6

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1987

10519

2.01

164.47

2.2

2.3

376.18

376.46

nmol/l

0.01

1847

9571

(3005719) IgG [Mass/volume] in Serum or Plasma

1713

8588

2.11

164.43

2.6

2.7

11.12

10.60

g/l

3.92

1564

7808

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1531

7367

2.19

163.24

11.4

8.6

24.13

24.27

mmol/l

0.78

1468

7042

(3028026) IgM [Mass/volume] in Serum or Plasma

1431

6702

2.24

163.10

1.8

1.9

1.38

1.36

g/l

0.13

1308

6028

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1095

4560

2.50

163.08

3.3

3.2

1470.62

2073.49

u/ml

0.32

943

3915

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

6617

49408

1.57

159.85

2.9

2.2

75.57

77.87

nmol/l

8.03

5921

43451

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

849

3155

2.78

159.02

4.3

2.6

208.10

198.22

2.05

809

2996

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1287

5853

2.30

157.16

2.2

1.9

2.48

2.13

ug/l

0.35

1134

5083

(3036489) Thrombin time

1037

4352

2.48

151.62

3.4

2.2

22.95

21.69

3.46

931

3862

(3018405) Lactate [Moles/volume] in Arterial blood

1119

4919

2.37

147.54

5.3

3.8

1.59

1.39

mmol/l

3.99

1095

4830

(3013707) Erythrocyte sedimentation rate by Westergren method

10803

91022

1.56

144.56

5.4

4.1

17.09

13.23

mm/h

82.96

10028

83269

(3000570) Elastase.pancreatic [Mass/mass] in Stool

868

3425

2.62

144.25

1.5

1.4

248.18

274.57

ug/g

2.87

524

2042

(3025941) Bacteria identified in Stool by Culture

1326

6330

2.19

143.49

1.4

1.2

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1098

4851

2.35

143.00

2.8

2.3

778.10

584.88

ug/l

0.47

1048

4572

(3021589) Normoblasts [#/volume] in Blood

7047

54256

1.53

142.95

17.2

9.8

0.00

e9/l

0.44

5930

44150

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

924

3813

2.51

139.83

1.6

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

245

411

6.04

138.83

2.4

1.9

4139.95

2991.93

e6/l

0.14

185

277

(3015377) Calcium [Moles/volume] in Serum or Plasma

5848

43461

1.54

138.40

3.9

3.3

2.33

2.35

mmol/l

17.99

5144

37466

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

828

3280

2.61

136.38

1.7

1.6

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

283

553

5.19

136.10

3.9

2.2

92.84

96.09

0.67

271

523

(3007164) IgA [Mass/volume] in Serum or Plasma

3165

20396

1.68

135.68

1.6

1.5

2.98

2.55

g/l

14.85

2019

11951

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

3510

23258

1.65

135.03

3.5

2.9

1.32

1.27

e6/l

0.12

2140

13396

(3020630) Protein [Mass/volume] in Serum or Plasma

2062

11778

1.86

134.18

2.3

2.5

65.33

66.15

g/l

4.43

1888

10522

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

3327

21829

1.66

132.72

3.8

3.1

2.83

2.13

e6/l

3.17

1963

12056

(3026692) Albumin [Mass/volume] in Peritoneal fluid

202

293

6.97

131.81

1.8

1.3

9.88

14.28

g/l

8.44

145

229

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

222

363

6.19

129.10

2.2

1.8

8174.81

12473.63

e6/l

0.30

139

194

(3033799) Differential panel - Peritoneal fluid

225

375

6.07

128.35

2.4

1.8

—

(3020891) Body temperature

1168

5560

2.19

126.78

7.2

4.5

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

359

902

4.05

126.22

2.1

1.3

1.51

1.29

promille

1.59

272

687

(3024928) Oxygen saturation in Venous blood

721

2772

2.67

125.98

4.2

3.2

—

(3026493) Urate [Moles/volume] in Serum or Plasma

4753

34314

1.54

125.46

3.5

2.8

4201.14

5449.88

umol/l

1.28

4140

29490

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1388

7087

2.05

125.30

2.7

2.4

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

4100

28661

1.58

124.78

1.9

1.7

15812928.45

27671562.76

pmol/l

0.96

3434

23183

(3035350) Ketones [Presence] in Urine by Test strip

7692

61400

1.48

124.60

5.1

3.8

0.00

estimate

1.14

1795

12230

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1773

9884

1.89

123.88

5.5

3.8

116.83

94.45

ng/l

11.56

1523

8350

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1187

5773

2.14

121.85

7.0

4.9

1.77

1.61

3.86

1131

5403

(3007930) Methemoglobin/Hemoglobin.total in Blood

1172

5687

2.14

121.00

7.1

4.9

0.89

0.88

0.28

1121

5318

(3021601) Nitrite [Presence] in Urine by Test strip

7645

61183

1.47

120.78

6.7

5.1

0.00

estimate

0.80

1691

11402

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

530

1767

3.07

120.57

7.0

6.2

12.29

11.78

mg/l

1.60

477

1594

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

2161

12923

1.77

119.86

3.0

2.4

6.70

7.31

ug/l

0.61

1892

10990

(3009261) Glucose [Presence] in Urine by Test strip

7716

61923

1.47

119.79

5.1

3.8

0.00

estimate

1.88

1630

11076

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1671

9254

1.90

118.89

6.1

3.8

5.06

5.14

kpa

3.67

1592

8704

(3044007) Cell count panel - Peritoneal fluid

203

332

6.18

118.04

2.1

1.9

—

(3037522) Nuclear Ab [Titer] in Serum

2367

14593

1.73

117.76

1.4

1.3

453.47

523.02

titre

1.28

499

3078

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

635

2368

2.75

117.70

6.3

5.4

615.84

1684.74

iu/ml

0.82

103

364

(3009343) pH of Capillary blood

1643

9146

1.89

114.84

6.1

3.8

7.42

0.30

267

1132

(44816559) Phosphatidylethanol [Mass/volume] in Blood

537

1898

2.89

110.03

1.8

1.3

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1587

8857

1.88

109.79

6.0

3.8

1.59

1.79

mmol/l

1.15

1156

6503

(3017181) Myelocytes/100 leukocytes in Blood

1820

10655

1.80

107.72

4.7

4.0

0.94

0.93

0.03

803

3792

(3015736) pH of Urine

6318

49639

1.45

104.77

4.5

3.5

5.85

5.84

0.04

240

2715

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

2225

13913

1.69

104.01

5.1

3.6

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

2071

12713

1.72

103.60

4.0

3.0

302.74

244.25

ng/l

4.69

1914

11597

(3002331) Protein [Mass/volume] in Peritoneal fluid

168

264

6.42

101.64

1.4

1.3

20.66

54.23

g/l

0.85

125

204

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

3306

22892

1.56

101.61

1.3

1.2

1.60

1.26

u/ml

0.90

817

5689

(1616796) Gas panel - Central venous blood

744

3217

2.38

101.09

4.8

3.5

—

(3028626) Oxygen [Partial pressure] in Capillary blood

788

3501

2.31

100.59

6.4

3.5

8.10

8.07

kpa

0.14

770

3423

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

13535

123242

1.59

100.30

32.0

15.6

26.06

26.48

mg/l

0.81

12358

99633

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1527

8655

1.84

100.14

2.0

1.7

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

2547

16641

1.63

100.02

2.1

1.8

—

(3002179) Metamyelocytes/100 leukocytes in Blood

1658

9670

1.80

98.91

4.5

3.9

0.75

0.68

0.39

702

3258

(3043409) Potassium [Moles/volume] in Arterial blood

898

4248

2.18

98.42

5.9

4.0

3.91

mmol/l

0.04

885

4210

(3015235) Bicarbonate [Moles/volume] in Capillary blood

812

3709

2.25

97.00

4.1

3.1

24.35

24.71

mmol/l

1.45

791

3637

(3047181) Lactate [Moles/volume] in Blood

899

4286

2.16

96.57

7.9

5.8

1.50

1.31

mmol/l

4.99

808

3784

(3019230) Fractional oxyhemoglobin in Venous blood

560

2208

2.59

92.74

4.5

3.0

61.06

63.74

1.71

555

2197

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

845

4002

2.17

92.23

2.1

1.7

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

1055

5524

1.97

87.71

1.4

1.6

15.51

16.21

u/ml

0.05

142

(3021440) Promyelocytes/100 leukocytes in Blood

1677

10144

1.73

87.53

4.9

4.0

0.10

0.00

670

3298

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

694

3106

2.29

86.92

1.4

1.3

—

(3004588) Protein electrophoresis panel - Serum or Plasma

1625

9764

1.74

86.84

2.2

2.3

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

619

2639

2.40

86.68

1.5

1.3

—

(3052851) Hemolysis interference index of Serum or Plasma

844

4127

2.10

84.70

4.3

3.3

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

410

1448

2.88

84.06

1.1

1.60

1.53

g/l

2.28

376

1297

(3021901) Oxygen saturation in Capillary blood

627

2725

2.35

84.05

3.5

2.9

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

5895

47029

1.40

84.00

5.5

4.1

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

914

4621

2.04

83.80

2.6

3.2

48.47

48.15

mg/l

0.02

726

3736

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1315

7502

1.82

83.80

1.5

1.4

—

(3025159) Blasts/100 leukocytes in Blood

1583

9546

1.73

83.33

4.9

4.0

0.07

0.33

2.97

573

2742

(3000012) Reticulocyte production index

529

2138

2.52

83.17

2.5

2.1

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

913

4628

2.03

83.10

2.6

3.2

190.45

58.23

mg/l

0.92

720

3746

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

892

4494

2.04

82.56

2.6

3.1

3.91

3.22

ratio

0.16

323

(3010421) pH of Blood

777

3720

2.14

82.36

6.4

3.9

7.42

1.63

694

3368

(40767503) Oxygen content in Capillary blood by calculation

666

3003

2.27

81.90

3.3

2.5

15.40

16.17

4.24

373

1585

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

292

862

3.43

81.13

1.5

1.3

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

3407

24816

1.47

79.42

3.6

3.1

2.47

2.46

mmol/l

3.80

2924

21488

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

683

3163

2.21

78.68

1.7

1.6

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

708

3333

2.17

78.29

1.3

1.2

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

219

545

4.06

78.07

7.0

4.1

71.96

526.42

mg/l

0.53

168

383

(42529406) Shigella sp [Presence] in Stool by Culture

707

3346

2.16

77.12

1.3

1.2

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

682

3195

2.18

76.32

2.8

2.2

121.98

128.80

g/l

8.45

544

2332

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

696

3304

2.16

75.31

1.3

1.2

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

596

2658

2.29

75.18

3.5

3.1

333.99

1077.53

u/ml

1.74

540

2421

(40760888) Immunoglobulin light chains.free panel - Serum

718

3459

2.12

74.80

2.6

3.3

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

197

477

4.17

72.89

3.4

2.5

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

706

3442

2.10

71.24

5.8

3.8

1.94

1.60

mg/l

12.96

657

3087

(3003181) Sodium [Moles/volume] in Urine

547

2411

2.31

70.91

1.8

1.3

59.64

63.02

mmol/l

1.13

422

1916

(3027315) Oxygen [Partial pressure] in Blood

682

3288

2.12

70.87

6.6

3.9

8.50

8.48

kpa

0.06

668

3194

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

648

3065

2.16

70.73

1.8

1.6

—

(3012501) Base excess in Blood by calculation

679

3272

2.12

70.64

6.6

3.9

2.66

2.56

mmol/l

0.43

491

2192

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

451

1827

2.51

70.53

4.0

2.9

651.94

6059.20

u/ml

0.64

122

(3013290) Carbon dioxide [Partial pressure] in Blood

679

3274

2.12

70.53

6.6

3.9

4.98

4.99

kpa

0.13

665

3181

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

101

8.75

70.14

3.2

1.8

54.00

62.14

0.76

(3028271) Lactate [Moles/volume] in Capillary blood

516

2231

2.36

69.92

2.4

1.9

1.83

1.73

mmol/l

1.30

499

2182

(40768441) Liver Pathology biopsy report

259

780

3.36

69.77

1.9

1.3

—

(3010375) cycloSPORINE [Mass/volume] in Blood

201

511

3.97

69.62

31.2

27.1

114.74

116.10

ug/l

0.10

168

426

(3029937) Albumin [Presence] in Urine by Test strip

4331

33649

1.39

68.91

5.5

4.2

0.00

estimate

0.06

1566

10745

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

514

2236

2.34

68.68

1.7

1.4

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

477

2010

2.41

68.49

1.7

1.5

109.93

115.49

u/ml

0.46

431

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

510

2221

2.34

67.97

1.7

1.4

18.95

18.82

u/ml

—

(3009508) Creatinine [Moles/volume] in Urine

5171

41478

1.36

67.09

3.7

3.2

7.06

7.61

mmol/l

15.22

4356

34327

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

819

4310

1.95

66.72

1.6

356.81

258.71

titre

0.37

190

(3003694) ABO and Rh group [Type] in Blood

4155

32218

1.39

66.42

1.5

1.4

—

(3026250) Tacrolimus [Mass/volume] in Blood

182

451

4.07

65.31

36.5

34.5

6.99

7.38

ug/l

1.36

158

407

(3042733) HLA Ab [Presence] in Serum

156

345

4.55

64.89

3.9

5.0

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

424

1736

2.48

64.82

1.1

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

634

3084

2.10

64.31

1.4

1.3

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

469

2028

2.35

63.53

1.5

1.3

310.84

269.65

u/ml

1.88

296

1261

(3028707) Methadone [Presence] in Urine by Screen method

351

1330

2.67

62.95

4.1

2.8

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

3825

29534

1.39

61.94

4.6

3.8

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

645

3210

2.05

61.51

1.5

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

645

3211

2.05

61.45

1.5

1.3

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

437

1863

2.38

61.13

1.5

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

425

1794

2.41

60.78

2.5

2.1

31.36

32.94

8.23

420

1779

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

238

745

3.23

60.27

1.1

1.0

295.93

286.31

mg/l

0.98

213

671

(3041096) Erythrocytes [Presence] in Urine by Automated

4112

32244

1.37

60.21

4.9

3.5

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

481

2160

2.26

59.64

1.5

1.3

—

(3000494) Fungus identified in Specimen by Culture

2035

14085

1.51

59.25

1.6

1.4

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

1182

7222

1.69

58.44

1.2

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

504

2334

2.20

57.97

1.7

1.6

—

(3022806) Fractional oxyhemoglobin in Capillary blood

415

1775

2.37

57.63

2.4

1.8

88.22

89.24

1.97

404

1751

(3022313) Gas panel - Capillary blood

1106

6663

1.71

57.60

6.9

4.0

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

881

4972

1.82

57.60

1.4

1.3

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

240

776

3.12

57.59

2.4

1.7

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

181

490

3.72

57.41

3.2

1.6

128.63

123.76

umol/l

0.07

257

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

413

1768

2.37

57.24

1.1

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1653

11016

1.56

57.22

6.4

3.8

1.22

1.23

mmol/l

5.33

1504

9505

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

8.69

56.33

3.4

1.7

15.88

17.70

0.13

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

681

3568

1.95

56.09

1.4

13.46

15.59

iu/ml

0.12

(3039000) Anion gap in Blood

605

3046

2.02

55.85

9.8

6.6

11.66

11.25

mmol/l

1.84

563

2723

(3018572) Chloride [Moles/volume] in Blood

605

3047

2.02

55.80

9.8

6.6

104.89

105.03

mmol/l

0.25

563

2724

(3020682) Albumin/Creatinine [Ratio] in Urine

5124

41910

1.32

55.66

4.2

3.8

17.70

9.38

mg/mmol

15.82

3534

26845

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

263

916

2.90

55.39

1.2

332.00

86.21

titre

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

263

916

2.90

55.39

1.2

145.51

173.14

titre

0.29

172

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

1534

10143

1.57

54.86

3.7

2.7

58.51

62.27

ml/min/173m2

3.04

730

4215

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

163

424

3.87

54.76

3.8

1.9

168.08

155.41

0.80

151

395

(40768804) Tissue Pathology biopsy report

5800

48370

1.31

54.45

2.4

2.2

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

453

2061

2.23

54.43

1.7

1.6

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

453

2061

2.23

54.43

1.7

1.6

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

13608

127540

1.41

54.38

37.1

18.5

139.00

139.61

mmol/l

116.96

13392

124004

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

932

5483

1.74

52.78

2.2

3.79

3.75

g/l

0.36

840

4863

(3011288) Drugs identified in Urine by Screen method

444

2029

2.22

52.78

3.5

3.1

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

934

5499

1.74

52.75

2.2

7.52

7.45

g/l

0.68

840

4873

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

932

5494

1.74

52.40

2.2

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

13617

127823

1.40

52.28

37.3

18.6

4.00

3.99

mmol/l

0.51

13375

124061

(3019150) Specific gravity of Urine by Refractometry

3509

27338

1.36

52.25

5.3

4.3

1.02

kg/l

0.75

545

4215

(3008037) Lactate [Moles/volume] in Venous blood

626

3271

1.95

51.95

5.0

3.3

1.71

1.66

mmol/l

0.52

615

3196

(3036180) Methadone [Presence] in Urine

149

378

3.97

51.86

4.2

1.8

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

10015

90033

1.29

51.52

4.2

3.8

14.95

14.94

pmol/l

0.04

8990

80415

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

7751

67549

1.28

50.52

3.1

2.7

—

(3012516) Albumin [Mass/volume] in Urine

4837

39675

1.31

50.22

3.6

3.2

550.95

371.72

mg/l

1.69

3415

25883

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

876

5139

1.74

50.06

2.1

2.2

10.39

10.32

g/l

0.15

779

4468

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

520

2579

2.05

50.02

1.6

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

434

2017

2.18

49.48

1.5

1.4

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1175

7471

1.62

49.42

3.4

2.9

0.39

0.30

e6/l

1.07

1154

7320

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

475

2292

2.10

49.18

1.5

1.4

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

415

1906

2.21

48.74

1.3

1.2

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

444

2106

2.14

48.07

1.2

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

332

1395

2.41

48.02

1.6

1.5

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

332

1395

2.41

48.02

1.6

1.5

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

483

2370

2.07

47.83

3.6

2.1

—

(4035726) Immunohistochemistry procedure

1570

10770

1.51

47.04

1.5

1.4

—

(3024932) HLA-DR beta [Type]

137

352

3.92

46.89

1.1

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

381

1725

2.24

46.35

1.6

0.75

0.85

g/l

0.77

289

1296

(3013512) EKG study

4709

38817

1.30

46.23

5.4

4.2

—

(3024471) HLA-A [Type]

138

362

3.84

45.88

1.0

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

833

4950

1.72

45.40

2.7

—

(3004809) Band form neutrophils/100 leukocytes in Blood

461

2267

2.06

45.39

3.4

3.5

1.64

1.57

0.16

411

1962

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

387

1780

2.20

45.30

1.5

1.4

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

602

3253

1.88

45.12

1.6

1.5

0.24

g/l

0.31

564

3072

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

855

5129

1.70

45.01

2.3

3.11

2.97

g/l

3.45

764

4502

(3045716) Anion gap in Serum or Plasma

182

579

3.17

44.97

2.8

2.2

10.25

9.57

mmol/l

1.36

177

561

(3024891) Influenza virus A+B Ag [Presence] in Specimen

589

3170

1.89

44.70

1.3

1.2

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

345

1531

2.28

44.05

1.6

1.5

—

(3044889) 12 lead EKG panel

9668

87307

1.26

44.04

5.1

4.1

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

617

3387

1.85

44.01

1.6

4.24

6.65

iu/ml

0.25

155

795

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

438

2145

2.07

43.61

5.1

3.2

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

611

3364

1.85

43.17

1.7

1.5

1.16

1.17

g/l

0.50

576

3179

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

389

1832

2.15

42.92

1.5

1.4

—

(3051651) Icteric interference index of Serum or Plasma

222

814

2.75

42.57

4.6

3.5

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

300

1272

2.38

42.56

1.2

64.70

65.27

u/l

0.04

273

1126

(3037756) Immunofixation for Serum or Plasma

572

3099

1.88

42.52

1.4

1.5

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

203

711

2.88

42.42

1.1

—

(40761535) Cells panel - Urine sediment

1609

11325

1.47

42.18

4.2

3.5

—

(40757494) Bilirubin.total [Moles/volume] in Blood

204

724

2.84

41.61

2.4

2.2

33.17

36.20

umol/l

0.09

(3003327) Ova and parasites identified in Stool by Light microscopy

605

3360

1.83

41.56

1.7

—

(3044242) Glucose [Moles/volume] in Arterial blood

190

654

2.93

40.99

2.0

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

777

4661

1.70

40.86

2.2

2.4

0.97

1.06

g/l

0.24

658

3909

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

191

662

2.91

40.70

1.1

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

191

664

2.90

40.48

1.1

1.0

—

(3051611) Lipemic interference index of Serum or Plasma

320

1433

2.26

40.02

4.2

3.2

—

(3002385) Erythrocyte distribution width [Ratio]

11233

103749

1.27

39.99

39.1

18.3

15.46

15.18

4.25

11088

101697

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

345

1595

2.19

39.91

1.6

1.4

—

(3038515) Glucose [Moles/volume] in Venous blood

567

3128

1.84

39.80

5.3

3.4

7.81

7.74

mmol/l

0.22

556

3063

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

693

4060

1.74

39.70

2.2

0.08

0.03

g/l

0.83

624

3668

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

717

4272

1.71

38.64

2.2

35.54

37.29

g/l

9.91

622

3631

(4281824) Cell count and differential, peritoneal fluid

255

1050

2.45

38.63

1.2

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

652

3785

1.75

38.57

2.2

2.3

0.00

g/l

0.11

584

3409

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

558

3097

1.83

38.41

1.5

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

480

2539

1.92

38.41

1.2

36.00

161.03

titre

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

349

1647

2.14

38.34

1.3

—

(40762365) Oxygen content in Arterial blood by calculation

233

4.27

38.21

3.5

2.7

13.94

14.84

ml/dl

2.10

215

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

307

1380

2.25

38.06

3.8

3.3

6.93

12.46

nmol/l

0.73

293

1347

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

110

281

3.93

38.03

1.3

1.2

102.68

100.75

0.17

101

259

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

641

3721

1.75

37.93

2.2

2.3

0.00

g/l

-0.00

582

3398

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

333

1552

2.17

37.77

1.6

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

334

1563

2.16

37.50

1.6

1.4

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

106

268

3.97

37.19

2.5

2.3

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

11868

110666

1.27

37.18

5.2

4.6

2.00

2.15

mu/l

2.03

10795

99667

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

330

1548

2.15

36.83

1.6

1.4

—

(3019977) pH of Arterial blood

210

807

2.62

36.78

2.5

2.6

7.42

0.00

298

(3016879) Cocaine [Presence] in Urine

519

2856

1.84

36.73

3.6

2.1

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

330

1551

2.15

36.65

1.6

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

329

1546

2.15

36.56

1.6

1.4

—

(3000093) Morphology [Interpretation] in Blood Narrative

297

1345

2.23

36.19

1.1

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

578

3308

1.77

35.92

3.4

3.1

0.81

nmol/l

0.04

447

2549

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

899

5781

1.59

35.82

7.8

4.2

24.37

24.82

mmol/l

4.02

831

5281

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

190

710

2.70

35.20

1.2

109.05

93.86

u/l

1.14

173

599

(3000764) Benzodiazepines [Presence] in Urine

541

3057

1.80

35.11

3.6

2.0

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

198

4.41

35.08

1.6

1.2

106.17

104.99

0.09

188

(3013005) Retinol [Moles/volume] in Serum or Plasma

122

354

3.46

35.05

3.6

1.6

1.83

2.01

umol/l

1.16

117

333

(3033705) Calcium.ionized [Moles/volume] in Venous blood

378

1909

2.00

34.64

3.4

2.4

—

(3028300) Cannabinoids [Presence] in Urine

543

3085

1.79

34.60

3.6

2.0

—

(3027008) Opiates [Presence] in Urine

540

3080

1.78

33.96

3.2

2.0

—

(40761536) Microorganisms panel - Urine sediment

1483

10692

1.43

33.83

5.6

4.1

—

(3003434) Protein [Mass/volume] in Pleural fluid

419

2216

1.91

33.57

1.6

1.5

28.27

32.36

g/l

8.42

372

1967

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

105

284

3.71

33.53

1.2

1.1

82.33

84.85

0.36

149

(3023199) Leukocytes [#/volume] in Pleural fluid

381

1964

1.96

32.94

1.6

1.5

4950.67

2308.21

e6/l

0.54

293

1404

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

103

279

3.71

32.83

1.2

77.86

84.05

0.75

151

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

845

5467

1.58

32.76

2.1

1.8

—

(3037121) Protein [Mass/volume] in Urine

742

4662

1.62

32.54

3.5

3.0

0.39

0.33

g/l

1.10

389

2023

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

907

5976

1.55

32.44

2.3

1.9

—

(3040151) Glucose [Moles/volume] in Capillary blood

341

1707

2.02

32.06

7.8

12.1

7.56

7.40

mmol/l

0.32

284

1408

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

381

1984

1.94

31.99

1.3

1.4

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

298

1426

2.11

31.65

1.2

1.1

113.86

115.67

0.35

273

1272

(3027944) Amphetamines [Presence] in Urine

523

3018

1.76

31.61

3.6

2.0

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

313

1529

2.07

31.47

1.3

1.2

4.45

4.50

u/ml

0.01

136

496

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

180

695

2.61

31.30

1.2

36.16

26.93

u/l

1.07

161

574

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

195

4.22

31.29

1.3

1.2

72.76

70.73

0.15

(3020961) Endomysium IgA Ab [Titer] in Serum

716

4511

1.61

31.04

1.2

1.1

119.38

266.52

titre

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

102

286

3.58

30.92

3.7

3.5

7.54

mg/l

0.00

229

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

195

4.17

30.43

1.3

1.2

82.57

78.09

0.42

(3017569) Oxygen content in Arterial blood

169

645

2.64

30.10

2.1

2.2

—

(40761511) CBC panel - Blood by Automated count

13260

126212

1.27

29.85

31.4

14.7

—

(3008295) Osmolality of Serum or Plasma

271

1280

2.14

29.80

1.5

1.4

275.58

278.79

mosm/kgh2o

1.09

207

957

(3016038) Potassium [Moles/volume] in Urine

208

882

2.38

29.65

1.6

1.1

32.53

36.02

mmol/l

1.36

175

732

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

216

934

2.33

29.45

1.5

1.4

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

245

1118

2.21

29.39

1.5

1.4

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

345

1789

1.95

29.36

1.6

1.5

72062.82

59735.65

e6/l

0.33

222

1052

(3020564) Creatinine [Moles/volume] in Serum or Plasma

13566

129565

1.28

29.21

35.1

18.3

90.44

82.60

umol/l

43.32

13559

129504

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

228

1013

2.27

29.18

1.2

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

415

2297

1.83

28.88

1.5

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

211

912

2.33

28.81

1.5

1.4

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

123

410

3.01

28.24

1.9

1.4

2863224.30

1580583.91

iu/ml

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

397

2184

1.84

28.19

1.2

1.3

40.07

36.40

u/l

0.24

350

1876

(3042517) Benzodiazepines panel - Urine

6.40

28.08

3.6

2.6

—

(21494755) Public health laboratory ask at order entry panel

478

7924

0.59

27.89

1.3

1.4

—

(3043410) Blood group antigens tested for on Red Blood Cells

113

362

3.14

27.78

2.3

1.7

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

208

908

2.31

27.77

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

297

1503

1.99

27.15

1.2

1.1

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

297

1505

1.99

27.05

1.3

1.2

3.71

4.11

u/ml

0.30

149

663

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

230

1059

2.19

27.02

2.4

—

(3045788) Cell count panel - Pleural fluid

295

1493

1.99

26.97

1.6

1.5

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

276

1364

2.04

26.96

1.8

1.6

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

269

3.47

26.95

2.9

2.8

148.31

146.46

au/ml

0.01

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

420

2384

1.78

26.90

2.7

2.3

3799.41

5155.33

u/l

0.48

118

923

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

181

754

2.42

26.89

1.6

1.5

7.57

6.61

u/l

0.25

135

602

(21494890) Protein electrophoresis panel - 24 hour Urine

291

1470

2.00

26.74

1.9

2.0

—

(36660697) Celiac disease serology panel - Serum

1153

8279

1.42

26.70

1.2

1.1

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

293

1489

1.99

26.48

1.4

1.3

571.83

451.68

u/l

0.26

275

1407

(3004451) EKG impression Narrative

171

699

2.46

26.48

1.3

—

(3020876) Protein [Mass/time] in 24 hour Urine

307

1597

1.94

25.94

2.8

2.4

1.18

1.29

g/24h

0.31

175

761

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

12080

114273

1.22

25.91

28.1

14.9

75.87

76.79

ml/min/173m2

3.56

10660

94571

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

258

1267

2.05

25.66

1.8

1.7

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

120

417

2.89

25.63

2.4

2.5

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

120

417

2.89

25.63

2.4

2.5

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

273

1375

2.00

25.33

3.0

2.9

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

415

2404

1.74

24.81

2.3

1.7

0.89

0.83

nmol/l

0.68

348

1985

(3017315) Amylase [Enzymatic activity/volume] in Urine

160

660

2.44

24.34

1.3

1.2

256.65

420.37

u/l

1.21

148

615

(3024139) IgG subclass 3 [Mass/volume] in Serum

229

1098

2.10

24.31

1.4

1.3

0.44

0.43

g/l

0.07

158

764

(3028192) IgG subclass 2 [Mass/volume] in Serum

229

1099

2.10

24.25

1.4

1.3

2.95

2.94

g/l

0.04

155

769

(3052592) Norovirus Ag [Presence] in Stool

293

3.22

24.25

1.5

1.4

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

222

1053

2.12

24.24

1.3

1.52

1.41

nmol/l

0.59

200

949

(3027135) IgG subclass 1 [Mass/volume] in Serum

229

1100

2.10

24.20

1.4

1.3

7.17

6.92

g/l

0.27

157

762

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

165

693

2.39

24.12

1.3

1.2

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

131

493

2.67

24.10

1.1

1.0

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

13501

129529

1.25

23.72

17.4

10.4

26.58

26.03

u/l

1.31

13145

124052

(4062490) Immunoglobulin typing, IgG

228

1102

2.08

23.71

1.4

1.3

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

275

1427

1.94

23.45

1.3

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

506

7940

0.63

23.43

1.7

1.8

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

727

4897

1.51

23.42

1.8

39.77

38.55

u/l

0.75

619

4235

(40768806) Pleura Pathology biopsy report

315

1710

1.86

23.41

1.6

1.5

—

(3049717) Cytology report of Urine Cyto stain

878

6152

1.45

23.19

2.7

2.8

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

295

1573

1.89

23.18

1.3

0.37

0.28

nmol/l

0.31

115

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

231

1132

2.06

23.16

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

231

1132

2.06

23.16

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

231

1132

2.06

23.16

1.6

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

159

4.04

23.14

1.5

1.7

60.79

42.79

pmol/l

0.72

130

(3023419) Bacteria identified in Sputum by Culture

365

2080

1.77

23.13

2.4

2.3

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

224

1087

2.08

23.06

1.2

1.1

94.99

95.32

0.06

212

1009

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

905

6401

1.44

22.73

3.2

4.30

4.42

pmol/l

2.47

797

5616

(3000330) Specific gravity of Urine by Test strip

971

6970

1.42

22.46

5.5

3.7

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

291

1566

1.87

22.25

1.3

0.64

2.42

nmol/l

1.08

275

1504

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

160

688

2.34

22.23

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

160

688

2.34

22.23

1.5

—

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

5.81

22.21

1.2

1898.81

1597.22

u/l

0.06

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

114

4.57

22.09

1.7

1.2

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

209

1006

2.09

22.01

2.4

2.3

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

263

1375

1.93

21.97

1.3

—

nmol/l

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

638

4243

1.52

21.85

1.1

1.57

1.01

u/ml

0.86

(3036782) Glucose [Moles/volume] in Pleural fluid

275

1463

1.89

21.79

1.5

1.4

6.70

6.30

mmol/l

1.43

257

1345

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

129

511

2.54

21.45

1.3

1.2

—

(3012441) Differential panel - Pleural fluid

308

1712

1.81

21.25

1.7

1.5

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

234

1192

1.98

21.11

1.3

13.11

13.81

u/l

0.10

208

1105

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

145

612

2.38

21.04

1.6

1.4

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

190

902

2.12

20.78

1.5

1.4

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

264

1411

1.88

20.65

3.6

3.4

60.92

57.35

1.81

223

1157

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

2110

17158

1.26

20.61

1.3

1.2

12.50

13.80

u/ml

0.31

753

6221

(3035637) Corticotropin [Mass/volume] in Plasma

269

1451

1.87

20.46

1.5

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

279

1527

1.84

20.27

4.0

3.9

—

(3005322) IgE [Units/volume] in Serum or Plasma

874

6292

1.41

19.88

1.3

326.36

269.71

u/ml

0.46

808

5797

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

109

414

2.64

19.78

2.1

1.9

18723.38

34196.38

u/ml

0.24

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

221

1131

1.97

19.71

1.4

15.10

13.09

u/l

2.90

210

1088

(3026389) Candida sp identified in Specimen by Organism specific culture

292

1640

1.79

19.51

1.4

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

2233

18386

1.25

19.49

1.3

36.13

35.96

iu/ml

0.01

691

5709

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

146

641

2.29

19.39

3.2

3.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

149

662

2.26

19.25

1.5

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

149

662

2.26

19.25

1.5

1.4

—

(3002256) Pathology report gross observation

1993

16249

1.26

18.93

1.3

—

(1761482) Bacteria [#/volume] in Urine by Culture

582

3921

1.50

18.77

6.4

4.2

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

270

1509

1.80

18.37

2.3

1.8

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

142

632

2.26

18.30

1.1

3.42

4.92

iu/ml

0.62

(3014148) Varicella zoster virus Ab [Titer] in Serum

222

1169

1.91

18.24

1.2

1.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

145

657

2.22

17.90

1.2

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

523

3481

1.52

17.89

2.1

2.3

195.80

117.25

ug/min

2.18

302

2054

(3015171) Extractable nuclear Ab [Units/volume] in Serum

593

4051

1.48

17.88

1.3

1.2

0.53

1.02

u/ml

1.15

389

(3020717) Zinc [Moles/volume] in Serum or Plasma

115

472

2.45

17.82

2.3

1.4

16.35

24.41

umol/l

3.17

108

453

(3019225) pH of Specimen

1666

13389

1.27

17.81

5.7

4.3

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1997

16395

1.25

17.77

1.6

1.5

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

4.82

17.72

4.8

2.9

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

145

664

2.19

17.46

1.2

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

237

1296

1.84

17.34

1.1

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

162

777

2.10

17.34

1.5

1.4

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

162

778

2.09

17.28

1.5

1.4

—

(40768446) Kidney Pathology biopsy report

111

455

2.45

17.27

1.8

1.6

—

(4200892) Spirometry reversibility

1153

8874

1.32

17.13

1.4

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

473

3118

1.53

16.94

1.8

1.9

12.11

11.65

mg/l

0.30

436

2887

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

532

3598

1.49

16.87

1.4

—

(3035880) pH of Pleural fluid

175

874

2.01

16.80

1.4

1.3

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

491

3271

1.52

16.75

2.0

1.7

—

(3023511) Choriogonadotropin [Units/volume] in Urine

210

1118

1.89

16.73

1.7

1.3

—

(3020393) Adenovirus Ag [Presence] in Stool

160

3.51

16.69

1.9

1.2

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

11809

112876

1.17

16.52

7.4

6.1

41.41

40.49

mmol/mol

16.47

10875

103057

(3022621) pH of Urine by Test strip

1099

8444

1.32

16.52

3.7

3.2

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

117

3.94

16.21

1.2

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

290

1717

1.70

16.18

4.8

4.5

353.44

348.17

umol/l

0.25

255

1442

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

5.81

16.14

2.3

2.1

140.14

177.87

ug/g

0.69

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

325

5180

0.62

16.12

1.4

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

180

923

1.96

16.06

3.6

2.1

20.77

9.20

umol/l

2.40

139

665

(3042631) Mycobacterium sp identified in Specimen

333

2050

1.64

16.01

2.6

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

404

2608

1.56

15.93

1.1

4.04

4.98

u/ml

0.23

228

(3006576) Bicarbonate [Moles/volume] in Blood

117

512

2.29

15.76

8.5

6.3

23.90

24.85

mmol/l

1.37

107

459

(3001186) Copper [Moles/volume] in Serum or Plasma

222

3.03

15.75

1.3

1.2

16.67

16.82

umol/l

0.09

198

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

5.01

15.68

4.2

3.4

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

375

2.49

15.05

1.2

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

126

585

2.16

14.74

1.2

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

123

569

2.17

14.53

1.1

1.06

1.07

ratio

0.33

190

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

177

3.17

14.29

2.2

2.8

56.77

70.77

mg/l

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

351

2.49

14.09

1.3

1.5

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

130

623

2.09

14.04

1.2

1.1

41.43

28.25

u/l

0.67

116

553

(21494434) Karyotype in Bone marrow

210

1185

1.78

13.96

1.2

1.1

—

(1761868) Lipid panel - Serum or Plasma

3370

38036

0.86

13.85

3.5

3.0

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

285

2.64

13.74

1.2

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

127

3.55

13.72

1.3

1.2

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

345

2.47

13.61

1.2

1.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

237

1396

1.71

13.56

3.6

3.5

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

4.92

13.54

1.0

1.1

34.14

22.08

u/ml

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

4.92

13.54

1.0

1.1

42.00

27.19

u/ml

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

194

3.00

13.47

2.2

1.4

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

129

627

2.07

13.45

1.2

1.1

101.30

90.85

u/l

0.45

117

562

(3045142) Bone marrow Pathology biopsy report

246

1470

1.68

13.35

1.3

—

(3011412) CD3 cells [#/volume] in Blood

195

1093

1.79

13.28

2.3

2.4

1.09

1.12

e9/l

0.19

177

976

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

204

1165

1.76

13.05

1.5

1.3

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

334

2.46

13.05

11.3

7.7

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1088

8630

1.28

12.85

2.3

2.0

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

295

2.55

12.85

1.2

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

153

3.21

12.79

3.9

5.6

68.73

51.16

ug/min

0.78

129

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

992

7807

1.29

12.47

2.2

1.9

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

196

1122

1.76

12.46

1.4

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

283

2.55

12.37

11.8

7.6

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

243

2.68

12.34

1.6

1.3

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

374

2.33

12.32

1.2

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

165

901

1.84

12.28

1.2

1.1

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

184

2.94

12.18

6.3

5.3

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

173

963

1.80

12.11

1.6

—

(3012565) Volume of 24 hour Urine

126

633

2.00

12.05

2.6

2.2

1753.83

1930.41

1.10

115

536

(3021788) Differential panel - Synovial fluid

355

2382

1.50

11.83

1.5

—

(3000475) Leukocytes [#/volume] in Synovial fluid

454

3196

1.43

11.82

1.8

1.6

19375.31

14674.81

e6/l

0.93

325

2293

(43055442) Apixaban [Mass/volume] in Serum or Plasma

215

2.75

11.79

1.6

116.32

111.00

ug/l

0.14

183

(3035320) C reactive protein [Mass/volume] in Body fluid

160

878

1.83

11.75

2.9

2.5

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

209

1242

1.69

11.65

1.6

1.5

24.26

27.71

0.86

142

770

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

371

2.30

11.65

4.1

1.8

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

159

3.02

11.40

1.3

8.52

247735.65

nmol/l

0.91

132

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

305

1999

1.54

11.37

1.1

1.2

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

100

3.60

11.29

1.3

1.29

0.96

ml/s/173m2

0.69

(3032057) Clostridioides difficile [Presence] in Stool

304

2.41

11.14

2.2

1.8

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

183

2.85

11.10

1.6

1.3

71.07

73.53

0.23

150

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

3.93

10.98

1.8

1.1

64.90

40.93

mg/l

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

148

811

1.83

10.95

2.0

2.1

—

(3003338) MCHC [Mass/volume]

10544

101023

1.12

10.92

42.9

20.1

330.03

332.30

g/l

100.71

10438

99959

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

196

2.76

10.90

1.4

1.2

940.45

223.31

u/l

0.44

146

(3004775) Volume in Urine collected for unspecified duration

196

1169

1.68

10.82

2.0

2.3

820.12

658.43

2.89

125

760

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

153

852

1.80

10.75

1.4

1.2

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

366

2.25

10.70

1.2

1.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

137

739

1.86

10.67

3.7

3.6

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

275

2.44

10.58

1.3

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

257

1652

1.56

10.49

1.6

1.5

61.97

61.74

0.03

170

1029

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

327

2214

1.49

10.48

1.2

2.86

4.49

u/ml

0.37

172

(3037692) Legionella sp identified in Specimen by Organism specific culture

435

2.12

10.42

1.2

1.4

—

(3044927) Protein electrophoresis panel - Urine

234

1475

1.59

10.39

1.3

1.2

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

114

588

1.94

10.19

1.8

2.3

1896.03

1278.19

u/ml

0.74

109

581

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

294

1961

1.51

10.15

1.7

1.6

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

381

2.18

10.14

1.1

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

133

3.09

10.12

1.9

2.1

1.15

1.55

mmol/l

0.54

(3029634) Reagin Ab [Titer] in Serum by VDRL

232

1471

1.59

10.07

1.9

2.1

3.67

5.92

titre

—

(3010503) CD19 cells [#/volume] in Blood

129

697

1.86

10.03

2.5

0.18

0.41

e9/l

1.01

124

666

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

211

2.61

10.01

1.1

7.48

12.78

pmol/l

—

(3045414) Leukocytes [Presence] in Urine

708

5499

1.30

9.89

2.2

1.9

—

(1175426) CD3 cells/100 lymphocytes in Blood

152

868

1.76

9.86

1.8

2.1

71.59

70.44

0.32

147

822

(3000492) Spirometry study

1302

10855

1.22

9.83

1.5

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

172

1020

1.69

9.75

1.4

1.3

20.88

26.39

u/l

1.79

141

839

(3041672) Baker's yeast Ab [Presence] in Serum

4.51

9.75

1.0

1.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

263

1733

1.53

9.64

1.1

4830.15

6586.95

iu/ml

0.09

364

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

330

2278

1.46

9.63

1.2

—

14.49

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

394

2813

1.41

9.57

1.4

498.80

549.18

mg/l

0.73

366

2665

(3028717) Thiamine [Mass/volume] in Blood

112

3.22

9.54

1.1

—

(3034426) Prothrombin time (PT)

359

2.18

9.50

1.2

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

112

589

1.91

9.49

1.5

1.4

62.95

63.21

0.02

483

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

352

2467

1.44

9.48

1.5

10.28

24.76

e6/l

2.05

272

1904

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

352

2471

1.43

9.40

1.5

1362.17

3739.10

e6/l

0.74

294

2010

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

3.86

9.37

4.0

3.4

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

352

2474

1.43

9.34

1.4

1.3

3.88

3.84

mmol/l

0.29

321

2317

(3042010) Triglyceride [Moles/volume] in Pleural fluid

207

2.56

9.33

1.4

1.2

1.47

1.23

mmol/l

0.10

137

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

219

2.52

9.31

2.3

1.7

101.97

113.80

au/ml

—

(3009542) Hematocrit [Volume Fraction] of Blood

13799

134858

1.15

9.24

48.4

22.8

37.47

40.13

139.33

12870

124874

(3017732) Neutrophils [#/volume] in Blood

1012

8276

1.24

9.22

3.5

3.0

5.97

5.17

e9/l

0.73

766

6356

(3016750) Collection duration of Urine

143

820

1.75

9.18

2.0

2.1

516.40

497.53

min

1.74

100

584

(3017704) Immunofixation for Urine

139

791

1.76

9.16

1.4

1.5

—

(3007461) Platelets [#/volume] in Blood

13803

134917

1.15

9.15

47.8

22.7

243.00

242.53

e9/l

0.29

13558

130722

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

375

2676

1.41

9.15

1.2

1.3

6.92

7.57

u/ml

0.08

423

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

371

2643

1.41

9.14

1.3

11.05

5.70

u/ml

0.47

275

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

673

5251

1.29

9.11

1.1

—

(3044941) Cell count panel - Synovial fluid

299

2048

1.47

9.11

1.5

1.4

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

126

3.02

9.08

4.4

3.1

1.68

1.21

mg/l

0.44

(3002619) Bacteria identified in Specimen by Culture

278

2.31

8.97

1.6

1.2

—

(3035941) MCH [Entitic mass]

13804

134974

1.15

8.91

47.6

22.6

30.24

30.39

15.82

13636

132478

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

330

2.19

8.89

1.2

1.1

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

201

1271

1.59

8.89

1.5

1.3

158643.83

152652.93

e6/l

0.04

147

861

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

336

2366

1.43

8.85

1.3

200.06

223.82

miu/ml

0.43

103

981

(3024731) MCV [Entitic volume]

13804

134985

1.15

8.85

47.6

22.6

91.47

91.31

3.06

13640

132490

(3039443) Prostate specific Ag panel - Serum or Plasma

147

2439

0.60

8.81

1.5

1.6

—

(3026361) Erythrocytes [#/volume] in Blood

13804

134996

1.15

8.79

47.8

22.7

4.21

4.47

e12/l

307.65

13504

130306

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

465

1.98

8.79

1.2

1.1

24.57

18.65

u/ml

—

(3000963) Hemoglobin [Mass/volume] in Blood

13806

135019

1.15

8.78

48.3

22.8

125.43

134.94

g/l

307.65

13635

132531

(3008536) Aspergillus sp Ab [Presence] in Serum

232

2.42

8.74

2.2

2.1

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

166

1006

1.66

8.72

1.7

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

467

1.98

8.68

1.3

1.2

323.75

208.22

ug/l

0.18

258

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

578

4449

1.31

8.68

3.1

3.5

52.63

78.24

u/ml

1.86

559

4248

(3010813) Leukocytes [#/volume] in Blood

13803

135011

1.15

8.66

47.8

22.7

7.29

6.89

e9/l

42.84

13512

130323

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

346

2461

1.41

8.63

1.7

3.59

4.48

iu/l

1.53

109

802

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

283

2.27

8.63

3.4

1.9

8.84

9.40

mg/l

0.35

229

(3023383) Lactate [Moles/volume] in Pleural fluid

504

1.93

8.57

1.5

1.3

2.86

3.52

mmol/l

1.59

458

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

121

675

1.80

8.56

1.9

1.8

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

121

675

1.80

8.56

1.9

1.8

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

168

1027

1.64

8.55

2.0

1.7

5.45

4.25

mg/l

1.42

155

971

(3001893) Eosinophils/100 leukocytes in Pleural fluid

506

1.92

8.47

1.5

1.4

2.19

2.92

0.47

427

(3027923) C peptide [Moles/volume] in Serum or Plasma

120

670

1.80

8.47

1.4

1.3

1.25

1.16

nmol/l

0.39

506

(3023420) DNA double strand Ab [Units/volume] in Serum

180

1123

1.61

8.44

1.2

1.4

32.80

23.12

iu/ml

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

392

2861

1.38

8.41

1.2

30.80

41.25

u/ml

0.33

156

(3028433) Virus identified in Specimen by Culture

418

2.01

8.40

1.2

1.1

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

4.29

8.38

1.1

1.6

—

(3016244) Insulin [Units/volume] in Serum or Plasma

100

530

1.89

8.33

3.2

3.0

26.64

26.28

mu/l

0.03

492

(3032773) Endomysium IgG Ab [Titer] in Serum

140

822

1.71

8.31

1.1

—

titre

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

327

2.15

8.27

1.1

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

176

1102

1.60

8.15

1.5

1.6

26.69

26.23

u/ml

0.04

242

(44786800) Granulocytes/100 leukocytes in Body fluid

216

2.41

8.10

1.4

1.3

25.56

23.87

0.11

170

(3044290) Cell count panel - Cerebral spinal fluid

320

2272

1.42

8.09

1.4

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

131

761

1.73

8.09

2.4

2.6

491.49

513.17

e6/l

0.18

109

632

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

153

930

1.65

7.99

1.2

1.3

45.00

464.75

titre

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

113

634

1.79

7.88

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

3.30

7.76

1.3

1.2

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

126

734

1.72

7.73

2.4

2.6

0.21

0.24

e9/l

0.65

112

630

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1899

16687

1.16

7.72

13.5

7.7

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

3.64

7.71

11.6

10.4

187.56

193.20

e6/l

0.02

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

148

901

1.65

7.70

1.2

1.3

61.67

67.14

titre

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

384

2.01

7.69

1.6

1.3

21.06

22.53

0.18

314

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

4.32

7.66

1.2

1.1

2.70

0.88

u/field

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

138

828

1.67

7.60

2.5

601.50

627.46

e6/l

0.22

129

791

(3006270) Folate [Moles/volume] in Blood

186

1202

1.55

7.56

1.2

331.59

339.86

nmol/l

0.20

140

962

(21494815) CD4 cells/100 lymphocytes in Specimen

158

983

1.61

7.55

2.1

2.3

36.91

37.19

0.07

153

962

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

422

1.95

7.51

1.0

1.1

91.12

97.21

1.08

324

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

377

2788

1.36

7.50

1.3

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

208

1381

1.51

7.48

1.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

361

2.03

7.48

1.1

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

378

2801

1.36

7.43

1.4

11.42

9.27

u/l

2.10

323

2239

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

183

1184

1.55

7.41

1.2

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

193

1265

1.53

7.37

1.2

86.95

49.61

u/ml

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

261

1821

1.44

7.32

1.2

1.1

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

386

2881

1.35

7.25

1.8

1.7

357.46

298.01

mu/l

1.48

352

2619

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

156

2.57

7.15

2.2

2.0

17.13

16.34

umol/l

0.15

156

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

181

1193

1.52

6.78

1.0

3.96

2.66

u/ml

0.43

492

(40761539) Cells [Type] in Urine sediment by Light microscopy

354

1.98

6.78

1.3

1.2

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

235

2.22

6.75

1.5

10.83

9.19

0.16

124

(3013466) aPTT in Blood by Coagulation assay

3.88

6.69

1.1

37.11

39.57

0.50

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

3.21

6.67

1.1

1.07

1.15

u/field

0.20

(3011985) Renin [Units/volume] in Plasma

226

1564

1.45

6.66

1.2

1.4

52.42

69.87

mu/l

0.71

193

1382

(3036603) Volume of Urine

135

837

1.62

6.60

1.6

1.5

1787.95

1877.10

0.67

130

805

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

270

1933

1.40

6.60

1.9

1.8

19.13

24.18

ug/l

0.84

262

1881

(3041918) Cholesterol [Moles/volume] in Pleural fluid

284

2.08

6.55

1.4

1.2

1.32

1.56

mmol/l

0.90

181

(21494814) CD8 cells/100 lymphocytes in Specimen

451

1.84

6.51

1.9

2.0

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

100

577

1.74

6.43

1.2

1.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

247

2.15

6.40

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

120

730

1.65

6.35

2.5

2.4

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

379

1.90

6.24

1.9

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

451

1.82

6.21

1.4

23.18

20.64

0.36

409

(3036670) Protein [Mass/volume] in Synovial fluid

417

1.85

6.13

1.2

34.18

40.78

g/l

2.13

218

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

136

866

1.57

6.00

2.3

2.2

17.45

17.83

nmol/l

0.19

127

814

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

3.24

5.98

1.3

1.2

—

(3010838) Calcium [Moles/time] in 24 hour Urine

270

1968

1.38

5.98

1.9

1.8

4.08

4.92

mmol/24h

3.87

224

1701

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

275

2014

1.37

5.92

1.2

32.67

42.58

u/ml

0.64

193

(3001019) Free T4 and TSH panel - Serum or Plasma

293

3912

0.74

5.85

1.7

1.6

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

111

678

1.64

5.82

2.6

39.28

37.61

0.37

372

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

540

4346

1.25

5.81

2.1

2.0

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

122

765

1.60

5.76

1.1

1.2

—

(3029075) Extractable nuclear Ab panel - Serum

299

1.98

5.74

1.1

—

(43055459) Dabigatran [Mass/volume] in Serum or Plasma

3.60

5.74

1.7

1.4

149.42

102.86

ug/l

0.31

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

104

628

1.66

5.71

1.1

—

(3047189) Immunofixation for 24 hour Urine

110

674

1.64

5.71

1.4

1.7

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

523

1.72

5.69

3.7

2.4

—

(3014271) Vancomycin [Susceptibility]

143

933

1.54

5.69

3.4

3.0

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

378

1.86

5.65

1.4

17.05

15.78

pmol/l

0.25

311

(40759836) Histone Ab [Presence] in Serum by Immunoblot

121

765

1.59

5.54

1.1

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

121

766

1.58

5.51

1.1

1.2

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

754

6323

1.20

5.46

1.2

109.28

138.69

iu/ml

1.29

248

2252

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

182

1260

1.45

5.44

1.1

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

3.23

5.43

1.5

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

523

1.71

5.43

1.9

1.5

14.67

9.08

ug/l

0.88

474

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

121

770

1.58

5.40

1.1

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

121

770

1.58

5.40

1.1

1.2

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

2946

31890

0.91

5.36

3.0

3.2

0.82

0.80

ug/l

0.32

2041

22115

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

121

772

1.57

5.34

1.1

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

174

2.24

5.30

1.3

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

174

2.24

5.30

1.3

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

174

2.24

5.30

1.3

1.2

—

(3014051) Protein [Presence] in Urine by Test strip

421

3330

1.27

5.29

3.1

2.6

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

521

1.69

5.24

1.2

1.3

45.00

63.22

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

5.00

5.24

1.3

1.1

—

mmol/l

—

(3004616) Nuclear Ab [Presence] in Serum

193

1362

1.42

5.22

1.3

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

118

753

1.57

5.22

1.5

2.0

2.52

2.93

u/field

0.27

530

(3000034) Microalbumin [Mass/volume] in Urine

180

1255

1.44

5.21

3.3

3.0

45.13

50.00

mg/l

0.13

133

931

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

127

827

1.54

5.14

1.2

1.1

—

34.80

—

(3036071) Salmonella sp Ab [Titer] in Serum

326

1.87

5.13

1.2

1.1

—

(3026480) Teichoate Ab [Titer] in Serum

127

2.44

5.10

1.1

—

2.40

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

116

2.50

5.02

1.0

1.1

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

416

1.76

5.00

1.7

1.3

64.41

58.34

0.80

352

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

104

652

1.60

4.98

2.3

2.6

211.91

209.93

u/l

0.09

104

647

(3007463) Buprenorphine [Presence] in Urine

4.69

4.98

3.1

8.0

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

424

1.75

4.97

2.5

2.8

29.08

28.20

umol/l

0.28

314

(3008898) HLA-B27 [Presence]

379

2988

1.27

4.92

1.1

—

(3006245) CD3-CD19+ cells/100 cells in Blood

419

1.75

4.88

2.6

2.3

13.18

12.15

0.16

383

(21491868) Cryoglobulin [Mass/volume] in Serum

419

1.75

4.88

1.3

1.2

1.78

0.33

g/l

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

3.33

4.87

24.5

9.1

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

118

2.46

4.85

1.2

1.1

75.24

80.36

ug/l

0.26

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

168

2.20

4.85

2.9

3.3

45.45

40.99

umol/l

0.63

137

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

132

879

1.51

4.85

1.4

1.2

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

203

1467

1.39

4.83

1.2

1.3

328.48

387.07

pmol/l

0.33

173

1240

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

12056

117955

1.08

4.81

5.4

4.8

6.22

6.04

mmol/l

32.20

10865

105870

(4212803) Bone marrow aspirate examination

137

2.34

4.80

1.0

1.1

—

(40757373) Influenza virus identified in Isolate

284

1.90

4.79

1.4

1.5

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

327

1.84

4.77

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

430

1.72

4.75

1.1

1628.47

1497.79

miu/ml

0.45

430

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

432

3475

1.25

4.75

1.9

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

2.88

4.75

1.4

1.2

—

(3000060) B lymphocytes [#/volume] in Blood

292

1.89

4.75

2.1

2.4

756.55

791.44

e6/l

0.02

160

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

138

2.32

4.73

1.2

1.5

—

(3012898) Urea [Moles/volume] in Urine

120

2.42

4.69

1.2

1.4

128.09

161.73

mmol/l

0.95

101

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

294

1.87

4.66

1.8

2.5

7.28

7.86

mmol/l

0.66

183

(3014891) Appearance of Pleural fluid

252

1.95

4.65

1.3

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

218

2.02

4.63

7.3

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

3.21

4.60

1.1

1.5

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

133

902

1.48

4.50

1.2

1.3

9.36

8.92

mmol/l

0.47

123

860

(3048879) Bone marrow aspiration report

430

1.70

4.49

1.8

1.7

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

142

2.26

4.45

1.1

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

130

880

1.48

4.45

1.3

2.20

2.17

mmol/l

0.12

116

817

(3034891) Synovial lining cells/100 cells in Synovial fluid

633

1.57

4.41

1.5

2.65

3.16

0.22

143

(3020491) Glucose [Moles/volume] in Blood

138

949

1.46

4.37

2.0

7.21

7.08

mmol/l

0.16

106

652

(3018738) Hemoglobin F/Hemoglobin.total in Blood

2.88

4.32

6.1

3.9

17.96

12.67

0.39

(3016018) Differential panel - Cerebral spinal fluid

164

1170

1.41

4.26

1.6

1.5

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

292

1.82

4.13

1.2

209.13

269.55

pmol/l

1.15

209

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

166

1200

1.39

4.02

2.0

2.2

1.96

2.00

u/field

0.03

469

(3051387) C reactive protein [Mass/volume] in Capillary blood

372

3008

1.24

3.97

4.1

3.6

30.84

29.38

mg/l

0.30

271

1970

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

150

2.14

3.94

1.6

1.9

—

(3013336) Amino acids [Identifier] in Serum or Plasma

4.45

3.92

2.8

2.7

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

362

2925

1.24

3.90

1.4

25.34

27.42

iu/l

0.59

307

2449

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

335

1.73

3.88

3.3

3.1

—

(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid

4.78

3.86

7.7

10.0

53.17

41.58

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

150

1074

1.40

3.86

1.1

—

68.94

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

2.77

3.84

4.9

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

108

733

1.48

3.72

2.1

108.27

130.37

ug/min

0.16

177

(3051593) INR in Capillary blood by Coagulation assay

112

766

1.46

3.71

11.7

10.9

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

227

1746

1.30

3.68

2.4

2.1

21.98

27.46

mg/l

1.29

460

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

3.82

3.68

2.7

4.1

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

245

1.84

3.68

1.9

1.5

138.80

122.81

ng/l

0.25

245

(3009871) Measles virus Ab [Titer] in Serum

296

1.76

3.68

1.6

1.7

—

(3007919) Fasciola sp Ab [Titer] in Serum

5.63

3.65

1.0

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

358

1.68

3.60

2.6

2.3

139.29

144.10

nmol/l

0.11

305

(3011325) HIV 1+2 Ab [Presence] in Serum

3.50

3.59

1.1

1.0

—

(3002523) Influenza virus A Ag [Presence] in Specimen

182

1362

1.34

3.59

1.1

—

(40768800) Prostate Pathology biopsy report

287

3585

0.80

3.58

1.1

1.2

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

538

1.55

3.56

2.2

2.0

—

(3045424) Erythrocytes [Presence] in Urine

261

2054

1.27

3.56

1.5

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

151

2.05

3.49

2.0

2.6

64.20

84.17

pmol/l

0.43

136

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

273

1.76

3.43

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

181

1364

1.33

3.42

1.1

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

488

1.56

3.42

1.8

1.6

3.96

9.51

nmol/l

0.57

409

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

289

1.73

3.38

1.4

1.5

10.62

9.21

ug/l

0.86

289

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

216

1.85

3.38

1.6

1.7

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

350

1.66

3.36

1.2

1.3

25.75

25.15

—

(3021374) Sirolimus [Mass/volume] in Blood

7.00

3.36

16.1

9.4

7.77

6.85

ug/l

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

140

2.07

3.36

1.6

1.7

53.03

44.90

umol/l

0.58

140

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

320

1.69

3.35

1.3

113.48

112.33

0.13

282

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

154

2.01

3.33

1.3

1.2

107.57

107.53

ug/l

0.00

100

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

532

1.52

3.31

2.2

2.0

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

532

1.52

3.31

2.2

2.0

—

(3026726) Creatinine [Moles/volume] in Specimen

108

2.22

3.30

3.5

2.5

236.50

425.19

umol/l

0.58

102

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

3.42

3.30

1.1

1.0

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

128

2.11

3.28

1.0

1.1

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

102

2.26

3.28

1.3

14.43

14.75

nmol/l

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

768

6754

1.14

3.21

1.3

55.59

55.44

au/ml

0.00

373

(3024263) Appearance of Synovial fluid

101

699

1.45

3.20

1.4

1.3

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

341

1.64

3.16

1.3

0.31

g/l

0.00

269

(40768443) Skin Pathology biopsy report

649

5648

1.15

3.15

1.2

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

2.73

3.14

2.2

1.7

—

(3019832) Treponema pallidum Ab [Presence] in Serum

821

7269

1.14

3.11

1.8

1.6

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

842

7469

1.13

3.10

2.4

28.94

23.03

au/ml

0.43

481

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

404

3396

1.19

3.02

1.8

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

2.89

3.02

3.2

3.7

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

5.83

3.02

1.7

1.3

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

3.55

2.98

7.9

9.3

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

636

1.45

2.97

1.4

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

530

1.49

2.96

3.0

2.2

56.28

53.84

umol/l

0.27

444

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

169

1.89

2.93

1.4

1.5

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

341

1.61

2.92

1.6

1.4

94.26

172.27

nmol/24h

1.16

341

(3023410) Appearance of Cerebral spinal fluid

146

1095

1.34

2.92

1.7

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

278

3396

0.82

2.90

1.6

1.7

6.67

3.83

mg/l

0.87

223

2487

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

258

1.71

2.88

1.3

1.2

92.15

54.55

mg/l

0.16

192

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

6.67

2.86

1.0

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

512

1.49

2.81

1.0

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

456

1.51

2.80

2.2

2.0

28.51

350.48

ug/l

1.29

426

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

333

2773

1.20

2.79

1.4

1.3

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

2.46

2.78

1.1

1.2

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

166

1.87

2.74

1.1

1.2

17.00

18.79

u/l

0.30

107

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

181

1.82

2.72

2.0

2.2

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

177

1379

1.29

2.71

1.3

1.2

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

148

1126

1.32

2.71

1.1

—

16.35

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

122

902

1.35

2.71

1.2

34.67

73.32

u/ml

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

229

1842

1.25

2.70

1.7

1.4

152.48

197.73

pmol/l

0.89

221

1779

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

302

1.62

2.69

1.1

—

(3000285) Sodium [Moles/volume] in Blood

189

1.80

2.69

1.2

1.1

—

(3050794) Legionella sp Ab [Presence] in Serum

105

2.10

2.67

1.1

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

3.75

2.67

5.0

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

2.28

2.66

1.2

1.1

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

164

1269

1.30

2.66

1.6

1.8

2010.00

1353.10

titre

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

1142

0.70

2.65

1.5

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

208

2591

0.80

2.64

1.5

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

122

906

1.35

2.64

1.2

32.63

38.17

u/ml

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

327

1.59

2.64

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

320

1.60

2.61

1.1

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

2.25

2.60

1.2

1.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

120

2.00

2.59

1.1

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

141

1.92

2.59

2.6

2.4

—

(37021550) Renin [Units/volume] in Plasma --upright

267

1.65

2.58

1.2

1.3

99.53

63.59

mu/l

0.55

197

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

2.30

2.57

1.1

1.2

—

(3002079) Sodium [Moles/time] in 24 hour Urine

507

1.46

2.55

1.2

151.92

165.77

mmol/24h

0.65

507

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

137

1042

1.32

2.54

1.3

1.5

0.27

0.31

nmol/l

0.46

105

809

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

2.50

2.52

1.7

1.5

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

2.50

2.52

1.0

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

129

974

1.33

2.52

1.0

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

277

1.63

2.50

1.3

1.2

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

1116

0.71

2.49

1.5

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.11

2.48

1.2

1.1

9.30

9.15

u/l

0.02

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

3.46

2.47

5.8

6.3

—

(3005033) Fetal Nuchal fold Thickness US

1112

0.71

2.44

1.5

1.4

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

111

1475

0.75

2.39

1.4

1.5

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

328

1.56

2.38

1.1

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

409

1.49

2.36

1.3

3.44

4.20

umol/l

1.38

380

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

393

1.50

2.36

4.5

5.2

67.55

69.84

0.22

314

(3003129) Base excess in Capillary blood by calculation

377

1.51

2.36

1.9

1.7

-0.13

0.37

mmol/l

0.31

350

(3033942) Copper [Moles/time] in 24 hour Urine

3.03

2.35

1.1

1.09

0.22

umol/24h

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

132

1.89

2.34

1.1

1.0

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

259

1.62

2.34

1.7

1.5

0.39

0.40

ug/l

0.07

148

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

184

1.74

2.30

1.0

1.3

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

178

1422

1.25

2.29

1.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

177

1.75

2.29

1.1

1.2

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

4.62

2.27

1.5

2.0

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

537

1.42

2.27

1.2

—

(3020618) Glucose [Moles/volume] in Synovial fluid

2.55

2.26

1.2

1.0

6.20

5.34

mmol/l

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

325

1.54

2.25

1.1

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

127

1.89

2.25

2.6

2.9

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

103

1368

0.75

2.23

1.4

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

171

1.76

2.23

1.1

1.2

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

186

1.72

2.23

2.1

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

103

1367

0.75

2.22

1.4

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

598

1.39

2.22

1.0

1.1

5.22

10.38

iu/ml

2.76

142

(3007733) Chloride [Moles/volume] in Urine

3.10

2.22

2.3

1.1

84.78

76.52

mmol/l

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

103

1366

0.75

2.21

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

103

1363

0.75

2.18

1.4

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

195

1.69

2.18

1.9

2.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1476

15830

0.93

2.16

4.7

32.68

32.70

0.02

1042

10640

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

105

793

1.33

2.10

1.8

1.7

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

3.50

2.05

1.1

1.3

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

2.50

2.00

3.5

3.6

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

312

2673

1.17

2.00

1.2

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

287

1.53

1.99

1.0

1.1

—

(4034850) Laboratory test

461

4065

1.14

1.98

17.3

10.9

—

(3051339) Copper [Moles/volume] in Blood

2.28

1.97

1.2

1.1

15.44

16.19

umol/l

0.19

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

186

1.67

1.96

1.0

1.1

—

(40762887) Creatinine [Moles/volume] in Blood

3.33

1.96

1.6

1.2

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

217

1.61

1.96

2.6

2.8

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

194

1.65

1.95

1.5

1.3

60.86

560.40

ng/l

0.65

132

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

692

1.33

1.93

1.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

435

0.60

1.91

1.1

1.4

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.05

1.90

1.0

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

284

1.52

1.85

1.3

1.2

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1.98

1.84

1.1

—

(40768793) Breast Pathology biopsy report

165

2012

0.82

1.83

1.4

1.3

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

4.17

1.82

1.2

1.0

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

2.06

1.80

7.1

10.5

—

(3025577) Chromium [Mass/volume] in Blood

117

921

1.27

1.78

2.0

2.39

2.23

ug/l

0.15

758

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

728

1.31

1.77

1.1

268.01

289.12

mg/l

0.44

638

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

111

871

1.28

1.74

1.3

1.5

—

(3026470) Cobalt [Mass/volume] in Blood

119

944

1.26

1.71

1.9

4.01

3.46

ug/l

0.24

109

855

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

569

1.34

1.68

1.5

1.6

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

126

1.75

1.67

1.1

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

1.86

1.65

1.0

1.1

0.05

0.53

u/ml

—

(3001729) Color of Synovial fluid

119

1.77

1.65

1.8

1.5

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

142

1.69

1.63

1.7

1.6

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

765

1.28

1.62

1.2

1.1

42.24

42.94

mg/l

0.04

638

(3042951) Complement C1q Ab [Units/volume] in Serum

2.38

1.61

1.0

1.1

—

21.72

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

687

1.30

1.61

1.0

1.1

4.17

8.50

nmol/l

0.79

143

(3013293) Extractable nuclear Ab [Presence] in Serum

144

1.67

1.56

1.4

1.6

—

(3025130) Human papilloma virus identified in Specimen

113

904

1.25

1.55

1.8

1.7

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

2.11

1.54

1.0

1.1

167.14

217.62

pmol/l

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

449

1.36

1.53

1.1

205.71

370.85

ng/l

0.74

111

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

138

1.67

1.51

1.1

—

(3006567) Chloride [Moles/time] in 24 hour Urine

2.86

1.50

1.2

1.0

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

11452

113194

1.04

1.45

4.5

4.0

1.36

1.29

mmol/l

16.12

10353

101761

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

672

1.28

1.45

1.3

1.5

6.86

6.17

u/l

0.14

569

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

252

1.47

1.44

1.1

1.2

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

277

1.44

1.43

1.1

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

328

1.40

1.41

1.4

1.2

159.87

134.88

nmol/l

0.27

238

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.82

1.41

1.9

5.4

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

658

1.28

1.40

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

254

1.46

1.39

1.7

1.8

—

(1617658) Protocol used for examination of sentinel lymph nodes

678

0.74

1.37

1.0

1.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

121

0.41

1.37

1.0

1.2

—

(3016135) IgD [Mass/volume] in Serum

2.61

1.36

1.0

1.1

32.67

126.58

mg/l

—

(3017509) Phencyclidine [Presence] in Urine

1.83

1.35

3.2

1.6

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

618

0.73

1.34

1.3

1.2

—

(3050129) First trimester maternal screen panel - Serum or Plasma

143

1705

0.84

1.34

1.5

1.4

—

(3013762) Body weight Measured

0.00

1.33

0.0

1.2

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

435

1.33

1.2

1.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

129

1.63

1.29

1.0

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

2.78

1.28

1.0

1.1

2120.00

1785.56

titre

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

227

1.45

1.25

1.0

—

(3046861) Legionella sp Ag [Presence] in Urine

1.82

1.25

1.0

1.1

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

131

1.60

1.23

1.0

1.1

6.00

17.80

iu/ml

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

105

860

1.22

1.2

1.3

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

147

1.57

1.22

1.1

1.0

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

180

1.50

1.20

1.0

1.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

505

1.29

1.19

1.1

2.50

2.89

u/ml

0.07

197

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

133

1.58

1.16

1.0

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

231

1.43

1.16

1.6

1.2

—

(36303858) Crystals [Presence] in Urine

2.50

1.15

1.0

1.2

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

2.05

1.15

1.5

1.4

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

520

1.27

1.10

1.2

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

4361

44648

0.97

1.10

4.5

21.91

22.21

0.59

2110

22852

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

399

1.30

1.07

1.1

—

(40765096) Chromosome analysis panel by Banding

391

1.30

1.06

1.2

1.1

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

186

1.45

1.05

1.4

1.2

21.88

20.24

mmol/l

0.73

154

(3004347) Hepatitis D virus Ab [Presence] in Serum

2.27

1.03

1.0

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

148

0.54

1.03

1.3

1.7

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

611

0.77

1.03

1.1

1.3

1.48

1.53

g/l

0.46

611

(1002224) Polysomnography panel

358

3926

0.91

1.02

1.1

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

130

1.54

1.02

1.0

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.87

1.00

1.0

1.2

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

1.76

1.00

1.3

1.6

2.27

1.34

mg/l

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.76

1.00

1.0

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

993

0.82

0.98

1.4

1.5

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

181

1.44

0.97

1.8

2.9

0.54

0.42

u/field

0.26

181

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

1.94

0.97

1.0

1.1

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

249

1.37

0.97

1.1

0.68

umol/24h

—

118

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

496

1.25

0.95

1.1

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

280

2532

1.11

0.94

1.9

187.17

198.31

pmol/l

1.08

258

2364

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

118

1375

0.86

0.93

1.2

7.68

7.56

mmol/l

0.15

1181

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

391

1.28

0.92

1.9

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

1.71

0.92

2.2

1.1

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.71

0.92

1.2

1.1

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1113

10609

1.05

0.92

2.2

2.1

11.73

12.22

nmol/l

1.00

949

9360

(3005011) Chlamydia sp Ab [Titer] in Serum

142

1.48

0.91

1.8

1.7

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

2.14

0.91

1.0

1.1

1.33

2.89

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

184

1.41

0.91

1.0

—

(3029396) Erythrocyte agglutination [Presence] in Blood

160

1.44

0.88

2.1

2.7

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

1.87

0.81

1.2

1.0

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

1.67

0.78

1.4

1.6

0.73

1.37

mg/l

—

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

1.67

0.78

1.4

1.6

1.51

1.30

mg/l

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

1.67

0.78

1.4

1.6

1.53

1.50

mg/l

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

156

1.41

0.78

1.2

6.05

8.56

mg/l

1.09

143

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

3181

31072

1.03

0.77

1.7

1.6

1.45

1.35

mmol/l

7.48

2654

25764

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1237

11887

1.04

0.76

1.5

1.4

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

101

871

1.16

0.76

3.6

5.0

329.96

95.33

u/ml

0.73

265

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

1.70

0.75

1.1

1513.78

359.79

u/l

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

559

1.20

0.74

1.1

—

(46236302) HLA-C [Type] by High resolution typing

1.84

0.73

1.0

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

1.84

0.73

1.4

1.2

—

(40763590) HLA-DQ beta [Type]

1.84

0.73

1.0

—

(3006462) Nitrate [Presence] in Urine

644

0.82

0.72

4.3

3.6

—

(3051101) Glucose [Moles/volume] in Cord blood

273

1.28

0.70

4.9

6.0

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

1.53

0.68

1.3

54.25

35.72

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

353

0.76

0.68

1.1

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

204

0.69

0.68

3.2

2.9

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.59

0.68

1.4

1.3

275.64

312.12

umol/24h

0.28

(40765089) Chromosome analysis panel - Blood by G-banded

238

0.71

0.67

1.0

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

203

0.69

0.66

6.4

5.8

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

604

1.18

0.66

1.1

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.52

0.62

1.1

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

252

1.27

0.62

1.3

1.2

—

(3030313) Adrenal Ab [Titer] in Serum

1.55

0.62

1.0

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

1.67

0.61

1.0

1.7

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

964

0.87

0.61

1.4

169.80

175.35

pmol/l

0.08

964

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.60

0.0

1.1

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

853

1.14

0.60

1.0

271.25

326.94

ng/l

2.29

580

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

854

1.14

0.59

1.0

762.27

713.45

ng/l

0.50

561

(4146454) Self-monitoring of blood glucose

170

1547

1.10

0.59

2.8

2.7

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

300

1.23

0.57

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

300

1.23

0.57

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

300

1.23

0.57

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

300

1.23

0.57

1.1

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

857

1.13

0.57

1.0

33.47

43.70

ng/l

2.38

571

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.48

0.57

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

238

1.26

0.56

1.2

1.3

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

1.54

0.55

1.2

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

159

1.32

0.55

1.1

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

357

1.20

0.54

1.4

1.3

38.68

34.03

0.26

230

(40760410) HLA-B [Type] by High resolution

1.58

0.54

1.0

—

(40760409) HLA-A [Type] by High resolution

1.58

0.54

1.0

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

1.58

0.54

1.0

1.1

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.46

0.54

1.0

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

730

1.14

0.53

1.2

1.3

1.67

2.21

u/ml

0.16

424

(3013862) HLA-DP [Type]

1.54

0.53

1.0

—

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

1.45

0.53

1.1

1.7

0.66

11.33

u/ml

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

125

1374

0.91

0.48

1.1

4.09

1.34

u/ml

0.64

705

(3020650) Glucose [Presence] in Urine

280

1.21

0.48

1.5

1.4

—

(40762814) Titanium [Mass/volume] in Blood

253

1.23

0.48

2.4

2.2

3.33

3.79

ug/l

0.36

(3015183) Erythrocyte sedimentation rate

447

1.16

0.47

1.3

1.2

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

103

1140

0.90

0.46

1.1

4.51

4.24

u/ml

0.08

554

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

163

1503

1.09

0.46

1.1

18.98

14.41

au/ml

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

218

1.24

0.46

1.6

1.84

2.16

ug/l

0.33

115

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.38

0.45

1.0

1.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

105

1157

0.91

0.44

1.8

1.7

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.37

0.44

1.0

—

(44813793) Dust mix specific IgE antibody measurement

695

1.12

0.44

1.1

—

(3009015) Lactate [Moles/volume] in Synovial fluid

148

1.28

0.43

1.3

5.30

6.23

mmol/l

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

275

1.20

0.43

1.1

0.39

17.54

u/ml

0.79

154

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.43

0.42

1.0

1.1

271.63

238.97

nmol/l

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.43

0.42

9.0

8.7

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.65

0.42

1.0

—

(40768795) Lymph node Pathology biopsy report

127

1165

1.09

0.42

1.3

1.2

—

(3035060) Mercury [Moles/volume] in Blood

0.00

0.41

0.0

1.8

—

13.63

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.41

0.0

1.0

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.39

0.40

2.5

2.8

—

(3044009) aPTT.lupus sensitive (LA screen)

1.36

0.40

1.3

1.2

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

182

0.77

0.39

2.0

2.7

126.78

143.38

ng/l

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

368

3523

1.05

0.36

1.7

42.56

42.75

nmol/l

0.05

351

3392

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

0.65

0.35

1.8

1.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

939

0.92

0.33

1.1

1.16

0.43

u/ml

0.58

293

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.30

0.33

1.0

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

482

1.12

0.32

1.2

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

5645

55982

1.01

0.32

5.1

5.2

4.13

3.91

ug/l

0.10

4928

49783

(3032868) Hemoglobin electrophoresis panel in Blood

1.30

0.31

1.5

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.30

0.31

1.0

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

131

0.76

0.30

1.5

1.1

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

184

1.20

0.30

1.3

1.2

29.10

51.51

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.31

0.30

1.2

1.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

278

1.15

0.29

1.1

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.26

0.24

1.1

1.0

—

(3019174) dRVVT (LA screen)

1.26

0.24

1.2

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

716

1.08

0.23

1.3

1.4

3.31

4.23

ug/l

0.95

626

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

1.28

0.23

1.0

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

153

1.18

0.22

1.1

—

(3020934) Sesame Seed IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.62

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

0.21

0.0

1.2

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

1.0

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

0.21

0.0

1.2

—

65.29

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

209

2011

1.04

0.21

1.5

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

0.00

0.21

0.0

1.2

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

0.00

0.21

0.0

1.2

—

(3027305) Fractional oxyhemoglobin in Arterial cord blood

0.00

0.21

0.0

1.2

—

35.92

—

(40758292) HTLV I+II Ab panel - Serum

173

1.16

0.20

1.6

1.4

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

193

1.14

0.19

1.0

1.1

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

281

0.89

0.19

1.3

1.4

21.40

32.26

nmol/l

1.17

251

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

1.19

0.18

1.1

1.2

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

352

0.91

0.18

1.2

1.5

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

247

0.89

0.17

1.1

1.0

15.77

12.27

u/ml

0.17

134

(3006598) pH of Arterial cord blood

119

0.84

0.15

1.0

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

429

1.07

0.15

1.0

1.1

0.99

2.44

u/ml

0.48

133

(3001556) Androgen free Index in Serum or Plasma

1.11

0.15

1.3

1.2

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

140

1.14

0.15

1.1

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.08

0.14

1.1

1.0

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.80

0.14

1.4

1.2

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

518

1.06

0.14

1.1

1.02

1.06

u/l

0.50

247

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

107

0.84

0.13

1.4

2.2

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

102

1058

0.96

0.12

1.1

6.98

4.11

u/ml

0.65

439

(3024869) Neuronal Ab [Presence] in Serum

251

0.92

0.12

1.2

1.1

—

(3035933) Granulocytes/100 leukocytes in Blood

292

0.92

0.11

1.5

1.4

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

233

2375

0.98

0.10

1.5

1.3

—

(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid

1.11

0.09

1.2

1.1

0.08

0.05

mg/l

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

1.04

0.09

1.4

1.3

1.50

1.35

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

12093

121041

1.00

0.09

5.5

5.1

2.44

2.64

mmol/l

98.94

11032

110046

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

625

1.04

0.09

5.5

6.3

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.13

0.09

1.3

1.1

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

1.07

0.08

1.0

133.67

167.46

g/l

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

11829

118126

1.00

0.08

4.9

4.5

4.27

4.50

mmol/l

98.52

10865

107917

(3022475) Manganese [Moles/volume] in Blood

0.82

0.08

1.4

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.82

0.07

1.2

1.1

—

(3003577) Lead [Moles/volume] in Blood

0.86

0.07

1.1

1.3

—

0.19

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1200

11933

1.01

0.06

1.6

—

(3041806) Other cells [#/volume] in Blood by Manual count

246

1.06

0.06

2.1

1.6

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

572

1.03

0.06

4.6

5.4

1088.88

6532.54

u/ml

—

107

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

786

7905

0.99

0.05

1.5

1.4

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

120

0.92

0.05

6.4

2.4

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

447

1.03

0.04

1.1

8.35

6.83

u/ml

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

119

0.92

0.04

1.2

1.1

1.66

1.73

umol/24h

0.07

119

(3027231) Wheat IgE Ab [Units/volume] in Serum

169

0.95

0.03

1.1

1.00

2.52

u/ml

0.44

149

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

11715

117073

1.00

0.02

4.9

4.5

1.36

1.42

mmol/l

42.93

10657

106224

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

122

1.07

0.02

5.1

4.9

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

147

1480

0.99

0.01

1.1

1.24

1.11

u/ml

0.09

664

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.06

0.01

1.9

1.5

—

(4094501) Cardiovascular stress test using bicycle ergometer

321

3201

1.00

0.01

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

124

1246

0.99

0.00

1.4

1.5

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

152

1526

1.00

0.00

1.1

4.05

5.24

u/ml

0.42

792

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.02

0.00

1.1

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

504

0.99

0.00

1.1

1.47

6.57

u/ml

0.67

159

(3034092) Cytoplasmic Ig cells/100 cells in Blood

140

1.00

0.00

15.4

8.9

—

(3022689) Creatine [Moles/volume] in Urine

368

1.01

0.00

1.3

1.4

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

145

0.97

0.00

1.2

1.1

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

177

1.02

0.00

1.1

1.2

22.22

44.37

mg/l

3.37

153

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

172

1720

1.00

0.00

1.2

1.1

2.56

1.78

u/ml

0.41

898

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

469

1.00

0.00

1.1

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

0.0

1.0

—

(40760512) CD34 cells/100 cells in Bone marrow

0.00

0.0

1.3

—

(3005593) Pancreatic islet cell Ab [Titer] in Serum

0.00

0.0

1.0

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

0.93

-0.00

1.0

1.1

—

6.22

—

(3017497) Pine Nut IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.04

—

(3025966) Peach IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.2

—

2.98

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(3014178) Parietal cell Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3035153) Lemon IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.2

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.97

-0.00

1.0

1.1

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

0.99

-0.00

1.1

—

(3033463) Neutrophils [#/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3008343) Lysozyme [Mass/volume] in Urine

0.00

-0.00

0.0

1.0

—

0.48

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

-0.00

0.0

8.9

—

(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.1

—

39.56

—

(3004560) Lymphocytes [#/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.96

-0.00

1.0

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

0.91

-0.00

1.0

0.77

3.02

u/ml

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

0.00

-0.00

0.0

1.1

—

(3028468) Fragments [Presence] in Blood by Light microscopy

0.00

-0.00

0.0

1.3

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: K11_GIBLEEDING – GI-bleeding

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

GI-bleeding

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for GI-bleeding (K11_GIBLEEDING)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints